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ON SPOILAGE AND PATHOGENIC
BACTERIA IN DAIRY PRODUCTS
GENERAL INTRODUCTION
Propionibacteria have a long history of use in the fermentation and dairy
industries.In the dairy industry, propionibacteria play important roles in the
development of the characteristic flavor, aroma, texture and eye formation in
Swiss cheese (Langsrud and Reinbold 1973a,b; Biede and Hammond 1979;
Rehberger and Glatz 1990).They are also well known for their ability to
synthesize vitamin B12 (Perlman 1978).
Propionibacteria are Gram-positive rods, nonspore-forming, pleomor-phic,
non-motile, mostly slow-growing aerobic to aerotolerant mesophiles that form
small yellow, orange, cream, and dark red colonies (Glatz 1992). The optimum
pH range for growth is between 6 and 7. However, there is no growth when the
pH is less than 4.5 (Hettinga and Reinbold 1972a; Hsu and Yang 1991). Their
ability to produce inhibitory metabolites has been studied from as early as 1972
(Hettinga and Reinbold 1972a, b,c).
Propionibacteria have become increasingly important to the fermentation
industries (Caulsen and Gaddy 1981; Datta 1981; Calvin at aL, 1985; Hendricks
et al., 1985; Blanc and Goma 1987a; Bodies ei at., 1987; Borderat al.,1987;
Boyaval and Corre 1987; Crespo 9.1 al., 1990; Emde and Schink 1990; Hsu and
Yang 1991; Lewis 1991; Lewis and Yang 1992).Fermentation of glucose or
lactate as carbon sources produces propionate, acetate and carbon dioxide.
Typically, 3 moles oflactate result in the production of a 2:1:1 molar ratio of
propionic acid; acetic acid; and carbon dioxide, respectively (Ray and Daeschel
1992). Propionic and acetic acids are the two major products derived from the2
fermentation of lactose. The yield of propionic acid changes from approximately
33% (w/w) at pH 6.1-7.1 to about 63% at pH 4.5-5.0.However, acetic acid
remains within the range of 9%-12% at all pH values. The succinic acid yield
decreases from 17% at pH 7.0 to 8% at pH 5.0.In contrast, pyruvic acid
produced during fermentation of lactose is reconsumed (Hsu and Yang 1991).
The production of acetic acid is closely associated with cell growth, whereas
propionic acid can be both growth and non-growth associated (Hsu and Yang
1991).
In the production of Swiss cheese, theinhibitory effects of the undis-
sociated forms of propionic and acetic acids are potentiated against Gram-
negative bacteria (Baird-Parker 1980) by the low cheese pH.However, the
extent of the fermentation also is restricted by the acidic pH (Neronova at al.,
1967; Ibragimova at al., 1969; Hettinga and Reinbold 1972; Herrero 1983;
Blanc and Goma 1987).In addition, propionic acid is also known as an
important mold inhibitor.As producers of propionic and acetic acids, the
propionibacteria could serve as alternative sources of these organic acids when
chemical synthesis becomes costly and environmentally prohibitive.
The concentration of diacetyl produced by strains of Propionibacterium
freudenreichii ssp. shermanii in milk (10 pg /ml) was found to be non-inhibitory
to yeast and non-lactic acid bacteria ( Lee gi al., 1970; Jay 1982; Perez-
Mendoza at al.,1983; Ro at al., 1979;and Marwaha a al., 1983).Both
propionic acid and diacetyl have attained GRAS (generally recognized as safe)
status as food additives in the United States (Basler pa al., 1987; Daeschel
1989).Other volatile compounds such as sesquitrepenes have also been
reported to be produced by propionibacteria (Dumont ei a 1978; Crow and
Turner. 1986; Crow 1987).3
Bovine lactoferrin, an antimicrobial component of colostrum and milk,
helps in the protection of infants (Bullen It at,1972; Brock 1980; Bullen 1981)
from gastrointestinal infections.Porcine pepsin cleavage of native lactoferrin
produces low molecular weight peptides inhibitory for some Gram-negative and
Gram-positive bacteria (Tomita gi al., 1991).Also, hydrolysis of native
lactoferrin at pH 2 and 120 °C produces active peptides which are bactericidal
(Saito et al., 1991).
Microbial peptides with pronounced antimicrobial activity are commonly
isolated from animals, plants, microbes (Sahl, 1985) and in non-sterile food
(Muriana, 1993). They are small and cationic with molecular masses between
3000 to 6000 (Roller 1991).Post-translational modification of precursor
peptides has been shown to introduce intramolecular thioether bridges to
cationic peptides such as Pep 5, nisin, and subtilin (Gross and Morel! 1971;
Kordel and Stahl 1986; Kordel gi al., 1989; ).Although these peptides offer an
important potential safety advantage over chemically synthesized preservatives
when incorporated into food, many peptides are not suitable owing to the
pathogenic nature of the producer-strains.Peptides such as colicins (Konisky
1982),epidermin and Pep 5 (Ersfeld-Dressen, H. at al.., 1984; Horner gt al.,
1989) may be useful in topical application in creams and salves, but are
unlikely to be approved for use in foods because of the nature of the producer-
strains (Roller 1991).
Propionibacteria are also important in the production of antimicrobial
substances including bacteriocins.Propionin A, an antiviral peptide isolated
from cellular extracts of P.freudenreichii was found to be inhibitory against
vaccinia viruses (Ramanathan at al., 1966).Propionins B and C have
demonstrated both in vivo as and in vitro activity against Columbia SK virus.4
The sizes of both peptides are between 1000 and 2000 Da. (Ramanathan at
DI, 1968).
Crude lactic cultures are known to inhibit some psychrotrophs in milk and
ground beef (Gilliand and Speck, 1974). A large number of lactic acid bacteria,
singly or in combination, display varying degrees of antimicrobial activity.
Methanol-acetone extracts of lyophilized fermented milk contain ninhydrin-
postive materials.These proteineous materials were reported not to lose
antimicrobial activity when exposed to 100 °C for 10 minutes (Pulusani at al.,
1979). The methanol-acetone extract was active at pH 5.4 and not inactivated
by pepsin treatment (Pulusani 2/ al., 1979).In another study, purified cationic,
low molecular weight material isolated from Streptococcus diacetylactis was
found heat stable and active towards several Pseudomonas species at pH 6.0
and lower (Branen gi at., 1975).Acidophilin, a low molecular weight
(approximately 700 daltons) nitrogenous compound from Streptococcus
diacetylactis and Leuconostoc citrovorum cultures was reported by Branen 21
al., (1975) and Shahani e.t.a, (1976, 1977)to have potent antimicrobial
activity.Acidophilin was also reported to be an antibiotic produced by
Lactobacillus acidophilus (Shahani gial., 1977).Antimicrobial compound(s)
from Streptococcus thermophilus are likely to be amines of low molecular
weights which are heat stable (Pulusani gi at., 1979).An antimicrobial
substance from Lactobacillus sp. strain GG was found inhibitory to Gram-
postive as well as Gram-negative bacteria but not lactobacilli (Silva at al.,
1987).It was active between pH 3 and 5 but not pH 5.3.The substance was
also found to be heat stable and resistant to proteinase K, a-chymotrypsin,
trypsin, and carboxypeptidase A (Silva el al., 1987).It could not be considered
a bacteriocin but it does resemble a microcin from some of the characteristics
studied (Asensio at gl., 1976; Baquero and Asensio 1979; Baquero and Moreno5
1984). The antimicrobial substance from Lb. sp. strain GG has a molecular
weight of less than 1000 daltons and is soluble in acetone-water (Silva at Di.,
1987).
Microcins are low molecular weight amino-acid-oligopeptide antibiotics
which are resistant to some proteases, extreme pH values and heat, and
soluble in methanol (Baquero and Moreno 1984).Bacteriocins are larger
proteins which can be inactivated by proteases. Microcin A15 (< 500 daltons) is
a bacteriostatic compound with a methionine moiety.Microcin B17, with a
molecular weight of 4000 daltons, is sensitive to pronase, subtilisin, and
thermolisin. Microcin C7, about 900 daltons, is senstive to trypsin and subtilisin
but loses little activity when exposure to 100 °C for 30 minutes. Microcin C7 is a
linear structure consisting of acetyl-methionine, arginine, threonine, glycine,
asparagine, alanine and a supposed ethanolamine entity at the carboxyl-
terminal end (Garcia-Bustos 2/ al., 1984). Microcins D15, D93, and D140 are
highly hydrophilic, basic and small peptides (Baquero and Moreno 1984).
Bacteriocins are proteineous compounds usually with bactericidal activity
against species closely related to the producer bacterium (Tagg at s31., 1976;
Barefoot and Klaenhammer 1983).Diplococcin (Whitehead 1933; Davey and
Richardson 1981) and nisin (Hurst 1966,1981; Hurst and Dring 1968; Delves-
Broughton 1990) are well-known bacteriocins produced by Lactococcus
cremoris and Lc. lactis, respectively. Nisin contains a total of 34 amino-acids
and unusual lanthionines (Gross and Morel!, 1971).Since 1969, nisin has
been approved as a preservative in processed cheese, cheese spread,
pasteurized milk (Delves-Broughton 1990) and dairy desserts (Roller 1991).
Ethylenediaminetetraacetic acid (EDTA), Triton X-100 and Tween 20 have been
used to potentiate nisin activity against Gram-negative organisms including6
Salmonella typhimurium and Escherichia coli(Stevens at al., 1991; Stevens
at al., 1992a, 1992b).
Other bacteriocins include pediocin PA-1 from Pediococcus acidilactici
(Gonzales and Kunka 1987; Lozano gia, 1992), found effective in preventing
spoilage of salad dressing (Gonzales 1989).Pediocin A from Pediococcus
pentosaceus has a broader-range of activity against food spoilage pathogens
(Fleming ?jai., 1975; Daeschel and Klaenhammer 1985; Daeschel 1989).
Although numerous bacteriocins from Gram-positive bacteria have been
isolated, characterized, and purified (Hale and Hinsdill 1973; Barefoot and
Klaenhammer 1984; Torreblanca at al., 1989; Kato at al., 1991; Mortvedt at DI,
1991; Muriana and Klaenhammer 1991; Fitzgerald at W., 1992; Guomundsdottir
at al., 1992; Hechard gi al., 1992; Henderson at al., 1992; Hill and Parente
1992; Hoick gt al., 1992; Jimenez-Diaz 2./ al., 1993; Mathieu at al., 1993; Piard
gtal., 1992; Stoffels at al., 1992; Tahara at al., 1992), veryfew from the
propionibacteria are documented. Propionibacterium acnes from the
cutaneous group, produces a bacteriocin bacteriostatic against both Gram-
positive and Gram-negative anaerobes (Fukushima and Nakamura 1978; Paul
and Booth 1988). The classical dairy propionibacteria also have been shown to
produce bacteriocins (Lyon and Glatz 1991; Glatz 1992; Lyon at al., 1993;
Grinstead and Barefoot 1992).
Propionibacteria grown in milk or cheese whey, including the medium,
cells, acids and any other antimicrobial substances produced, may be dried and
used as a natural preservative. For example, MicrogardTm (Ayres at al., 1987), a
grade A skim milk product (Wesman Foods, Inc., Beaverton, Oregon) fermented
by P.freudenreichii ssp. shermanii and pasteurizedisused as a
biopreservative in cottage cheese (Weber and Broich 1986). Approved by the
Food and Drug Administration (Sandine at al., 1992), it has been estimated that7
30% of the cottage cheese produced in the United States has MicrogardTM
(MG) incorporated (Daeschel 1989).
Initial studies of MG showed that it prolonged the shelf life of cottage
cheese by inhibiting psychrotrophic spoilage bacteria (Weber and Broich 1986;
Salih and Sandine 1990).Subsequent studies (Al-Zoreky at al., 1988) have
shown that MG is antagonistic toward most Gram-negative bacteria except
Escherichia coli V517.Certain yeasts and molds, but not Gram-positive
bacteria, are inhibited by MG (Al-Zoreky at al., 1988).Non-dairy MG is also
commercially available for use with non-dairy products.The antimicrobial
substance in MG is proteineous since it can be inactivated by a-chymotrypsin,
papain, and pepsin (Al-zoreky 1988).MG is not inactivated by trypsin,
suggesting the presence of trypsin inhibitors.Such activity was reported in
some food systems (Konishi ei at., 1985).Unlike the antimicrobial substances
from lactic acid bacteria (Anderson 1986; Gonzalez gi a[., 1987), the active
ingredient in MG is heat stable.
Propionic, acetic and lactic acids present in MG could be responsible for
the inhibtory action against Gram-negative psychotrophs. The ratio of propionic
acid and acetic acid in MG is about 1:3.5 (Al-Zoreky 1988). The concentration
of diacetyl in MG is insufficient to be inhibitory to bacteria. The metabolism of
lactate by P.freudenreichii ssp. shermanii ATCC 9616 did not produce
succinic acid, contrary to the findings of Crow (1987). Furthermore, the addition
of catalase did not cause bubble formation indicating that hydrogen peroxide
was not the inhibitory substance in MG (Al-Zoreky 1988).Vorob"eva el al
(1987) and Hitchner (1934) reported that P. shermanii has the ability to
produce catalase and peroxidase.
Bovine albumin was found to be antagonistic toward MG, confirming
reports that albumin and other substances can antagonize those antimicrobial8
compounds produced by bacteria (Schales, 1951; Shibasaki gt al., 1978;
Kabara 1978). EDTA did not interfere with the antimicrobial ability of MG (Al-
Zoreky 1988). However, EDTA in itself could be inhibitory to bacterial growth
(Bulgarelli at al., 1985). The active ingredient in MG was determined by gel
filtration to be 700 daltons in molecular weight.However, purified fractions
were found to have lost activity when stored under refrigeration temperature for
a period of 2 months (Al-Zoreky 1988). This is in contrast to a non-proteineous
antimicrobial substance, isolated from Lactobacillus bulgaricus, which was
stable at 6°C for only 18 days (Abdel-Bar giaL, 1987).
The research reported in this thesis involved further characterization of
the active components in MG.It was desirable that the organic acids be
removed during the purification process of MG.In Chapter 1, organic acids in
MG were quantified by gas-liquid chromatography (Mitruka 1975; Drucker 1981;
Thornhill and Cogan 1984), and the known concentrations of these acids were
used to simulate inhibitory activity against Ps. putida (Figure 1.7).In addition,
the active ingredient in crude dairy MG was quantified and examined for its
stability when hydrolyzed under acidic or basic conditions.In this study, we are
interested to know if the antimicrobial substance(s) in MG resembles the active
precursors of lactoferrin upon heat and pH treatments (Saito at al., 1991).
In Chapter 2, the purification process of bacteriocin involved ultra-
filtration, anion exchange chromatography, gel-filtration and reverse-phase high
performance liquid chromatography. The low molecular weight peptide was
then analysed and sequenced for its amino-acid contents. Mass spectroscopy
was used to characterize its charge-groups and molecular weight.
The effect of chelating agents on nisin have been studied by Stevens at
al. (1992a, 1992b).In Chapter 3, sodium citrate and EDTA were used to
potentiate the antimicrobial effect of MG against Gram-positive and Gram-9
negative bacteria and yeasts.In this study, the effect of chelating agents and
MG were tested in broth and milk system.10
CHAPTER 1
GAS-LIQUID CHROMATOGRAPHIC ANALYSIS AND EXTRACTION OF
VOLATILE COMPOUNDS FROM MICROGARDTM
ABSTRACT
Various methods were investigated to remove volatile acids from
MicrogardlM (MG).It was found that the predominant organic acids were acetic
and propionic acids.There were also traces of lactic acid and diacetyl.
Lyophilization was employed to remove allvolatile acids through low
temperature (liquid nitrogen) evaporation. Gas-liquid chromatographic analysis
of the lyophilized samples showed a reduction in the amount of acetic and
propionic acids. Although the residual acetic and propionic acids were 76.3%
and 74.5% of that originally present, respectively, the use of ethyl-acetate was
found to be efficientin removal of the remaining acids.Gas-liquid
chromatography detected approximately 37.3% acetic acid and 20.3%
propionic acid remaininginthe aqueous phase.Anion exchange
chromatography was found effective in removal of essentially all acetic and
propionic acids from crude MG. Gas-liquid chromatography quantitated 6.3%
acetic acid and 2.98% propionic acid from the anion exchanged eluates.
Disk-activity assays showed that lyophilized (pH 6.34), ethyl-acetate
extracted bottom fraction and eluates from the anion exchanger remained
inhibitory toward the indicator-organism.This provides evidence that the
antimicrobial activity of MG could not be solely due to acetic or propionic acids.11
INTRODUCTION
Previous studies by Al-Zoreky (1988, 1991) showed that the antimicrobial
activity of MG is due to acid presence as well as a proteineous substance.It is
possible that the latter material could be a low molecular weight bacteriocin and
to ensure that MG activity was due to both acids and bacteriocin the study in this
chapter was undertaken.
It is well known that organic acids such as acetic, propionic, lactic acids
and diacetyl are bacteriocidal at low pH values (Hettinga and Reinbold 1972 a,
b, c; Hsu and Yang 1991). Therefore, it would not be surprising that a portion of
MG activity was due to these metabolic products.However, publications
dealing with bacteriocins produced by Propionibacteria are few in number and
only recently, reports being made by Lyon and Glatz (1991), Lyon at al. (1993),
and Grinstead and Barefoot (1992).
The present study was carried out to further characterize the active
components of the commercially available MG.It was desirable that the organic
acids be removed during the purification process of MG. Complete removal of
organic acids from MG would be necessary to show the presence of a
proteineous bacteriocin.In this chapter, organic acids in MG were quantified by
gas-liquid chromatography (Mitruka 1975; Drucker 1981; Thornhill and Cogan
1984), and the known concentrations of these acids were used to simulate
inhibitory activity against Pseudomonas putida..In addition, the active
ingredient(s) in crude dairy MG was quantified and examined for its stability
when hydrolyzed under acidic or basic conditions. After hydroysis at various pH
values, the antimicrobial substance(s) in MG was examined for any similarity
with the active precursors released by lactoferrin (Saito g3 al., 1991).12
MATERIALS AND METHODS
Preparation of MicrogardTM
Liquid dairy MicrogardTM (pH 6.38) was obtained from Wesman Foods,
Inc., Beaverton, OR. The crude MG was adjusted to pH 4.00 with anhydrous
tartaric acid to precipitate casein. All pH adjustments were made with a Corning
125 pH meter. The sample was then centrifuged at 10,000 x g for 30 minutes.
Supernatnant was decanted into another container and back-neutralized to pH
5.30 with 1.0 N NaOH. The supernatant was then filter-sterilized using a 0.45
gm pore diameter filter (Nalge Co., Rochester, NY) and stored at -40 °C.
Preparation of growth media
Rehydrated Plate Count agar (Difco Laboratories, Detroit, MI) was
prepared according to manufacturers' instructions and aliquoted (100 ml) into
dilution bottles. The pH of medium was adjusted with 10% tartaric acid solution
to pH 5.30 before autoclaving.Lactose broth (Difco Laboratories, Detroit, MI.)
was prepared and aliquoted (10 ml) in screw-capped tubes for the cultivation of
indicator-bacteria.The pH of lactose broth was 7.00.Both media were
autoclaved at 121°C for 15 minutes.
Activity detection assay
Disk-activity assay (Branen at ai., 1975; Pulusani gi al., 1979; Reddy at
al., 1983) was the method of choice used in the comparison of relative activity of
various MG fractions with the untreated controls. Ps. putida ATCC 12633 was13
inoculated into 10 ml of lactose broth and incubated at 30°C for 18 hours. The
overnight culture was used as the indicator-bacterium. A 1.0% stock solution of
2,3,5-triphenyltetrazolium chloride (Sigma Chemical Co., St. Louis, MO) was
prepared and filter-sterilized as for the MG supernatant. A total of 0.5 ml of
Pseudomonas culture was inoculated intomolten plate count agar (100 ml)
after tempering at 45 °C for 30 minutes. A total of 2.0 ml of 1.0% 2,3,5-
triphenyltetrazolium chloride (TTC) stock solution was added to the molten agar.
TTC was used as a colony coloring agent as the indicator-bacteria reduced the
compound to an insoluble red formazan (Figure 1.6). A total of 18 ml of the
bacterial-TTC mixture was aliquoted onto sterile disposable petric plates (100 x
15 mm, VWR Scientific Inc.).Analytical paper disks (0.5 inch Schleicher &
Schuell Inc., Keene, NH) were saturated with 100 pl of sample on the surface of
solidified PCA.Activity-assays were conducted at pH 5.30, the optimum pH
value for MG. All culture-plates were incubated agar-side down at 30 °C for 18
hours.
Lyophilization of crude MicrogardTM
One of the main concerns in this project was to completely remove all
organic acids found in dairy MG.It has been established that the predominant
organic compounds found in MG are acetic, propionic, and lactic acids as well
as diacetyl (Al-Zoreky 1988). The proposed method was intended to remove
the volatiles at a vacuum of 150 millitorrs and a temperature of -40 °C.It was
reasoned that lyophilization under such conditions would cause the acids to
volatilize and evaporate from crude MG.
A volume of 100 ml of crude dairy MG was titrated with 10% tartaric acid
solution or 0.1 N NaOH solution to pH values of 5.00, 5.30, 6.34 or 8.00.14
Titrated samples were lyophilized overnight to complete dryness.All dried
samples were rehydrated to their original volumes with 0.1 M citrate buffer, pH
5.30.The pH values were measured with a Corning 125 pH meter. Treated
samples were assayed for antimicrobial activity at pH 5.30 as described above.
Quantitation of protein in ultra-filtrated fractions
The objective of these experiments was to isolate the antimicrobial
substance from crude MG which was estimated to have a molecular weight of
700 daltons (Al-Zoreky 1988).Pre-treated dairy MG samples were filtered
through various molecular weight cut-off membranes at high pressure under
nitrogen gas as described below.All retentate and filtrate samples were
assayed by the disk-activity method for antimicrobial activity at pH 5.30. Active
molecular weight cut-off filtrate or retentate were analyzed for total protein
concentration by the Lowry Protein Assay (Sigma Protein Assay Kit P-5656).
Crude dairy MG (100 ml) was titrated with anhydrous tartaric acid to pH
4.00. The sample was then centrifuged at 10,000 x g for 30 minutes. The
supernatant was decanted into another container and adjusted to pH 5.30 with
0.1 N NaOH. A total of 250 ml of this sample was placed into an Amicon
filtration cell unit #8050 (Amicon, Inc., Beverly, MA) with molecular weight (MW)
cut-off membrane of 10,000 daltons (labeled by manufacturer as YM 10 >
10000 MW) at a pressure of 30 psi. A total of 247 ml of 10,000 MW ultra-filtrate
(10,000-F) was collected. The retentate (10,000-R) was washed with 0.1 M
citrate buffer, pH 5.30 and the remaining 225 ml ultra-filtrate (10,000-F) was
placed onto another MW membrane of 5000 daltons (YM 5 > 5000 MW) at a
pressure of 40 psi.All retaintates (5000-R & 1000-R) collected were washed
with 0.1 M citrate buffer (pH 5.30). A volume of 222 ml of 5000 MW ultra-filtrate15
(5000-F) was filtered through a 1000 daltons MW membrane (YM 2 > 1000 MW)
at 45 psi. A 500 daltons membrane (YCO5 > 500 MW) was used to filter the
1000 MW ultra-filtrate.All collected samples were tested for antimicrobial
activity by the disk-assay. Active fractions were also quantified for total protein
concentration by the Lowry Assay. The protocols used in this assay were as
established by Sigma Protein Assay Kit No. P5656.
Protein separation by Isoelectric- focusing
Isoelectric focusing (Egen 2/at., 1984) is a sensitive technique for protein
separation based on the principle that protein migration in an electrically
charged field will cease at its isoelectric point. The isoelectric point of a protein
is defined as the point of electrical neutrality (zero-charge). Operationally, the
Rotofor Preparative lsoelectric Focusing Cell Model 3000 Xi (Bio-Rad
Laboratories, Richmond, CA) requires a column stabilizedwith an
anticonvection agent and a pH gradient within this stabilized column. Hence,
there is a tubular system containing an anticonvection system within a linear
gradient.This gradient must contain the macromolecules (proteins) to be
analyzed along with ampholytes. Ampholytes are small polymers containing
randomly distributed weak acids and bases.
This system is connected to dilute acid and alkali electrode pools and a
voltage is applied.Applied voltage initiates the current or ion flow.In the
absence of added salts or buffers, the ampholytes are the major source of ions
in the system.These ampholytes migrate according to their charge
distributions; that is, those with lower isoelectric points (more carboxyls) migrate
toward the acidic electrode pole, and those with higher isoelectric points (more
amines) move to the alkaline electrode pole.Eventually, a pH gradient of16
ampholyte molecules that have migrated to their isoelectric points is produced.
The proteins of filtrated dairy MG when injected into the system also act like
ampholytes in that they migrate as a function of their (+) and (-) groups. As the
ampholyte-dependent pH gradient forms, protein molecules migrate to the pH
regions in the pH gradient where the attractive forces on protein molecules are
equal. This is the pH at which the number of (+) and (-) charges on any protein
are equal at its isoelectric point. Once the pH gradient forms and the isoelectric
focusing of individual proteins into specific bands have taken place, the applied
current must be turned off.
The active filter-sterilized supernatant from MG was isoelectric focused
by the Rotofor Preparative Isoelectric Focusing unit (BioRad). The apparatus
has cathode and anode termini which consist of membranes saturated with 50
ml 0.1 M phosphoric acid or 0.1 M NaOH, respectively. A mixture consisting of
2.5 ml of 2% ampholytes (pH range 3-10), 2 ml of 1000 M.W. filtrate and 45.5 ml
of distilled water was prepared before injecting into the apparatus. The voltage
was set at 1000 V and power at 12 W. After 4 hours of separation, 20 1 ml-
fractions were collected from the fractionator column and assayed for
antimicrobial activity at pH 5.3.
Ethyl-acetate extraction of organic acids from MicrogardTM
Acetic and propionic acids were thought to contribute to the inhibitory
activity of MG. However, it was established that the principal antimicrobial
substance in MG was proteineous.Therefore, to prove that a portion of the
activity of MG was a protein (bacteriocin), removal of all organic acids was
necessary.Organic solvent extraction was attempted to remove acetic and
propionic acids from MG.17
Crude dairy MG was acidified to pH 4.00 so that the casein proteins were
precipitated. The treated sample was centrifuged at 10,000 x g for 30 minutes
and the supernatant neutralized to pH 5.30.A total of20 ml of active
supernatant (pH 5.30) was extracted with an equal volume of ethyl-acetate
solvent for 1hour.The top fraction (T1) and bottom fraction (B1) were
separated and allowed to evaporate under vacuum to dryness using a rotary-
evaporator.The temperature of the rotary-evaporator was set at 70 °C to
remove the organic solvent. Upon evaporation to dryness, T1 was rehydrated
with distilled water and along with B1 subsequently extracted with equal
volumes of ethyl acetate for ten more times.All samples from T1 (1st time
extraction), and B1 (1st time extraction) to T10 (10th time extraction) and B10
(10th time extraction) were assayed for activity.All fractions were analyzed for
the presence of acetic and propionic acids by gas-liquid chromatography
(GLC).
A volume of 20 ml of 1000 MW ultra-filtrate (1000-F) was extracted with
an equal amount of ethyl-acetate for 1hour.The top fraction and bottom
fraction were separated and allowed to evaporate under vacuum to dryness
using a rotary-evaporator. Both fractions were rehydrated with distilled water
and analyzed for the presence of acetic and propionic acids by GLC.
Anion Exchange Chromatography
Amber lite IRS-400 anion-exchanger (hydroxyl-form) was found to be
effective in binding organic acids, resulting in the elution of acid-free active
ingredient(s) from crude MG.
After washing with deionized water, the resin was packed into a glass
column (2.5 cm x 60.0 cm) and then equilibrated with 1.0 M sodium carbonate18
overnight.After equilibration, the resin was washed with deionized water to
remove the excess sodium carbonate and hydroxyl-residues. The resin pH
after washing was within the range of 5.30 to 6.00. A total of 60 ml of crude MG
was loaded onto the column and the flow-rate was adjusted to 1.0 ml/min. After
the sample was completely immersed in the resin-bed, another 60 ml of
deionized water was used to eluate the non-acid materials from the column.
Eluates from the anion exchanger were collected in 4.0-ml fractions. A reducing
agent, D-L dithiothreitol(1 mM), was added to each of the fractions. After the
wash, 60 ml of 1.0 M sodium carbonate was used to regenerate the resin.
Only active fractions were combined and passed through another anion-
exchange column (0.7 cm x 25.5 cm).Active fractions from anion exchange
chromatography were analysed by gas-liquid chromatography for the presence
of organic acids.
Organic acids quantitation by gas-liquid chromatography
Concentrations (gg/g) of acetic and propionic acids were determined by
GLC on a Hewlett Packard 5710-A Gas Chromatograph & Integrator 3390-A.
The standard curve was determined with known concentrations of acetic and
propionic acids (Thornhill and Cogan 1984). The column (solid phase) used
was 80/120 Carbopack B-DA/4% Carbowax 20 M (Supelco Chromatography
Products, Inc. Bellefonte, PA). Inert nitrogen gas was used as the mobile phase.
The flow-rate of nitrogen gas was established at 24 ml per minute (60 psi). The
column temperature was 175 °C while the temperature of the injection port and
detector were set at 200 °C.The increase in temperature with respect to time
was 4 °C per minute.During combustion, hydrogen and compressed gases
were set at 38 and 20 psi, respectively.19
A standard curve for acetic and propionic acids was used to quantitate
the amount of these acids found in treated MG. Oxalic acid (0.03 M) was used
as buffer and internal standard. Lyophilized ethyl-acetate-extracted and anion
exchanged fractions were suspended in equal volumes of 0.03 M oxalic acid.
A total of 1ptl of mixture was injected into the GLC column. The column was
cleaned and equilibrated with 0.03 M oxalic acid.
Acid hydrolysis of Microgarem
Lactoferrin when hydrolyzed at acidic pH and high temperature has been
found to increase in activity (Saito ot oL 1991). The acidity and thermal stability
is similar to that of MG and therefore, in this study we attempted to confirm that
the active ingredient in MG is not due to the presence of lactoferrin.
Crude dairy MG was adjusted to pH 4.00 to precipitate casein proteins. It
was centrifuged at 10,000 x g for 30 minutes. The supernatant was collected
and aliquots adjusted with 1.0 N HCI to pH 1.00, 2.00, 3.00, and 4.00,
respectively. A total of 5 ml of each sample was placed in screw-capped tubes.
Temperatures of 50 °C, 60 °C, 70 °C, 80 °C, 100 °C, & 121 °C were
administrated to each sample. Each sample was heated at these temperatures
for 5, 15, or 60 minutes. After hydrolysis, all samples were back-neutralized to
pH 5.30 and then assayed for activity.
Base hydrolysis of MicrogardTM
Crude dairy MG was adjusted to pH 4.00 to precipitate casein.The
titrated sample was centrifuged at 10,000 x g for 30 minutes, after which the
supernatant was removed and aliquots adjusted with 1.0 N NaOH to pH 9.00,20
10.00, 11.00 and 12.00, respectively.A total volume of 5 ml of each sample
were placed into screw-capped tubes. Triplicate samples then were placed in a
water bath at 50 °C, 60 °C, 70 °C, 80 °C, 100 °C or 121 °C. for 5, 15 or 60
minutes. All samples were assay for activity at pH 5.3.21
RESULTS
Gas-liquid chromatography analysis of lyophilized MicrogardTM
The inhibitory activity of lyophilized MG was retained for all samples
(Table 1.1).However, there was a decrease in activity for samples at pH 6.34,
8.00, 5.30, and 5.00. There was no change in activity between the pH range of
5.30 to 8.00.GLC analysis showed the ratio of acetic to propionic acid in
untreated MG was 1:3.8 (Table 1.6). Also, there was a small amount of diacetyl
detected by the GLC, estimated to be 10 µg /g.Lyophilized MG showed a
substantial reduction in the concentrations of acetic and propionic acids (Figure
1.3 & Table 1.6). The percent reduction of acetic acid at these same pH values.
and 8.00 were calculated to be 40.4%, 56.7%, 76.3%, and 69.6% respectively.
The percent reduction of propionic acid at pH 5.00, 5.30, 6.34, and 8.00 were
calculated to be 43.4%, 61.8%, 74.5%, and 67.7% respectively.The
concentrations of acetic and propionic acids were extrapolated from the
standard curves (Figure 1.1). A new standard curve was generated when an
analysis was made and figure 1.1 present typical data which were highly
repeatable. The chromatogram of untreated crude MG is presented in Figure
1.2.
Gas-liquid chromatography analysis of ethyl-acetate extracted MicrogardTM
Ethyl-acetate was partially effective in the removal of organic acids from
1000 MW ultra-filtered MG (Figure 1.4).The extraction of acetic and propionic
acids from 1000 MW ultra-filtrate showed that the concentration of acetic acid
remaining in the top (organic-phase) and bottom (aqueous-phase) fractions22
were 0.905% and 59.82% respectively (Table 1.8).The concentration of
propionic acid in the top and bottom fractions from 1000 MW filtrate were
2.542% and 29.13%, respectively (Table 1.8). The concentration of acetic and
propionic acids in the top-fraction (organic-phase) of crude MG were 0.884%
and 1.813%, respectively (Table 1.7). The acetic and propionic acids in the
bottom fraction (aqueous-phase) were calculated to be 37.26% and 20.25%,
respectively (Table 1.7). The disk-activity assay showed that the top fraction
was more inhibitory than the bottom fraction (Table 1.4). There was no activity
in the middle fraction.Ethyl-acetate extraction of 1% non-fat milk used as a
control generated fractions which produced no zone of inhibition.
Total protein concentration and activity of ultra-filtered fractions
During ultra-filtration, the antimicrobial substance(s) of MG could diffuse
through the 10,000 MW (10000 MW), 5000 MW, 1000 MW, and 500 MW cut-off
membranes (Figure 1.7 - 1.10).All filtrates were found to possess inhibitory
activity when assayed against, Ps. putida ATCC 12633. The retentate (brown
precipitate) from 10,000 (10000-R), 5000 (5000-R), 1000 (1000-R), & 500 (500
R) molecular weight cut-off membranes revealed no antimicrobial activity
(Figure 1.11Figure 1.14 and Table 1.2).
Lowry total protein assay measured the amount of proteins and amino
acids in the 10,000, 5,000, 1,000 and 500 molecular weight cut-off filtrates.
Concentration decreased from 1695 ug/ml in 10,000-filtrate to 687 ug /mI in 500
filtrate (Table 1.2).23
Separation of active protein by isoelectric focussing
The active protein(s) from the 1000-molecular weight cut-off filtrate
(1000-F) was separated by the isoelectric focussing technique.Bands of
macromolecules (proteins) generated from the ampholyte-dependent pH
gradient were collected into twenty 1-ml fractions. Fractions 1 to 6 (pH 2.21- pH
5.13) were found to be inhibitory for Ps. putida. However, fraction 1 (pH 2.21)
was most inhibitory (Table 1.3).Control experiments with ampholytes (pH
range 3-10) fractions did not produce any inhibitory activity toward the indicator-
organism (data not shown).
Removal of acetic and propionic acids from crude Microgard by anion-
exchange chromatography
Fractions 5 to 16 from the anion-exchange column were found to be
inhibitory for Ps. putida(Table 1.10).Fraction 8 had the highest activity,
showing a 1.80 cm zone of inhibition toward the indicator-organism. Combining
fractions 5 to 16 did not increase the overall activity, but actually decreased it to
1.60 cm (Table 1.11).A second anion-exchange chromatography of the
combined samples yielded two active fractions (2 and 3). There was increased
activity in both fractions (Table 1.12). Also GLC showed an improvement in the
removal of acetic and propionic acids from crude MG (Figure 1.5). After anion-
exchange chromatography, the percent recovery of acetic and propionic acids
from crude MG was 6.30% and 2.98%, respectively (Table 1.9).24
Lactoferrin determination by acid-hydrolysis of crude MicrogardTM
The acid-hydrolysis of MG at pH 1.00, 2.00, 3.00, or 4.00 resulted in an
increase in antimicrobial activity (Table 1.13Table 1.16). The increase was
corelated with an increase in hydrolysis temperature from 50 °C to 121 °C.It
was seen, therefore, that the treated MG became more active after fifteen
minutes of heating at pH values from 1.00 to 4.00.
Lactoferrin determination by base-hydrolysis of crude MicrogardTM
Base-hydrolysis of MG at pH 9.00, 10.00, 11.00, and 12.00 showed a
slight increase in activity at 121 °C (Table 1.17Table 1.20).However,
progressive increased in temperature did not seem to enhance the activity of
MG. Overall, the data showed that a 15-minutes hydrolysis time was sufficient
to see slight increase in activity at 121 °C. The optimum temperature for a short
period of hydrolysis was 80 °C.With 5-minutes of hydrolysis, there was an
increase in activity of MG treated at pH 9.00, 10.00, and 12.00.25
DISCUSSION
Although propionic and acetic acids have been identified as the
predominant propionibacterial fermentation products (Hsu and Yang 1991),
concentrations of these acids in MG could not contribute significantly to
inhibition of food spoilage bacteria by this product. GLC analysis of crude MG
showed that the concentration of acetic acid is greater than propionic acid. This
finding is in contrast to that of Glatz 2/ ai. (1991, 1992, and 1993) who claimed
that the predominant acid in MG was propionic acid.It also contradicts the
observations of Marcoux at ai. (1992) who reported that a higher concentration
of acetic acid was produced when fermented ammoniated condensed milk
permeate was used to supplement a fermentation carried out by P.
freudenreichiissp. shermanii. The concentrations of lactic acid and diacetyl
also were too negligible to be inhibitory. Nonetheless, reports exist (Grinstead
and Barefoot 1992; Glatz 1992; and Lyon gi al., 1993) indicating that the
inhibitory activity of MG parallels the concentration of propionic acid.In the
present studies, the acid and base hydrolysis of MG have taken into account the
pKa-values of acetic (4.757) and propionic (4.874) acids. Undissociated forms
of these acids are inhibitory to Gram-negative bacteria (Tang ed al., 1989; and
Baird-Parker 1980).However, the ionized forms of these acids and other
volatile substances should be mostly destroyed at 121 °C for 15 minutes.
Heat treatment of MG at low pH values caused an enhancement in its
activity against Ps. putida.Since GLC analysis (data not shown) showed no
sign of acetic and propionic acids, it was reasoned that these acids were
destroyed and the activity of MG was likely due to a stable metabolite.This
stable substance was sensitive to a-chymotrypsin, pepsin and papain (Al-
Zoreky 1989), inferring that it was proteineous in nature.Bacteriocins from26
propionibacterial species are known to be thermal stable and resistant to a
wide range of pH levels (Grinstead and Barefoot 1992; Glatz 1992; and Lyon at
al.., 1993). We found that alkaline-hydrolysis was slightly inhibitory toward the
indicator-bacteria. This could be due to the release of active precursor(s) from
MG when hydrolysed under high temperature and pH conditions.
Hydrolysis of MG under acidic conditions did not produce the same
pattern of antimicrobial activity known to activate lactoferrin precursors. Saito el
ai. (1991) indicated that bovine lactoferrin, upon heat treatment under low pH
conditions, had antimicrobial activity.In their studies, an enhancement of
antimicrobial activity was observed when lactoferrin was heat-treated at pH 2
and 3. The inhibitory activity of MG after acid-hydrolysis could be due to the
release of active precursors different from lactoferrin molecules.
The antimicrobial activity of crude MG was only slightly reduced when it
was lyophilized at pH 5.00 .GLC analysis of this lyophilized product showed a
59.6% reduction in the concentration of acetic acid and a 56.6% reduction of
propionic acid.Lyophilization at higher pH values did not significantly reduce
amounts of these acids. The decrease in activity of the pH 5.00 dry product
inferred that the remaining undissociated acetic and propionic acids could still
contribute to some of the overall antimicrobial activity of MG.However,
simulated concentrations of the acetic and propionic acids at this pH 5.00 in the
lyophilized fraction were found not to be inhibitory to Ps. putida either
individually or when combined.
Ethyl-acetate extraction of crude MG followed by evaporation of the
organic phase under vacuum, caused the concentrations of acetic and
propionic acids to diminished significantly.When the organic phase (top
fraction), organic-aqueous interface (middle fraction) and aqueous phase
(bottom fraction) were evaporated under vacuum, the total recoverable acids27
were less than present in crude MG.Compared to the original acid
concentrations in crude MG, 37.26% of acetic acid and 20.25% of propionic
acids were still recoverable from the aqueous fraction after ethyl-acetate
extraction.However, only 0.88% of acetic acid and 1.8% of propionic acids
remained in the top extracted fraction.From these data, it appeared that
organic solvent extraction and evaporation resulted in volitilization of the
organic acids causing their loss from the treated MG. Since some amino acid-
oligopeptide antibiotics are known to be soluble in organic solvents (Baquero
and Moreno 1984; Garcia-Bustos at a1., 1984; Silva at al., 1987), it was not
surprising that the top fractions of extracted MG and the 1K molecular weight
cut-off filtrate were more inhibitory than the bottom fraction.Although the
concentrations of organic acids were greater in the aqueous fraction, it is our
belief that the antimicrobial substance(s) from MG must be soluble in organic
solvent.
The concentrations of acetic and propionic acids in the ethyl-acetate
extracted fractions (1000 MW filtrate) were found to be non-inhibitory to Ps.
putida.Also the same concentrations of propionic and acetic acids in 11%
non-fat dry milk (40.05 ppm of acetic acid and 29.79 ppm of propionic acids)
produced no inhibitory effect against Gram-negative bacteria. Since the ethyl-
acetate extracted fraction (1000 MW filtrate) remained active, these acids could
not be responsible for the antimicrobial activity of MG.
Anion-exchange chromatography (Bryant and Overell 1953) has proved
to be successful in removal of acetic and propionic acids from MG. GLC
showed that the original concentration of acetic acid in crude MG was reduced
to 6.30%.The concentration of propionic acid was reduced to 2.98%.
Successful reduction of organic acids should dispel any speculation that the
inhibitory nature of MG was mainly due to an acid-effect. (Glatz 1992; Lyon at28
al..,1993).The data hereinindicate that repeated anion-exchange
chromatography can ensure complete removal of all organic acids thus paving
the way for the purification of the antimicrobial substance(s) remaining in acid-
free MG.
From the ampholyte-dependent pH gradient, bands of macromolecules
in MG were generated after isoelectric focussing.The inhibitory activity of
eluted bands increased as the pH decreased from pH 5.46 to pH 2.95 .It is
known that macromolecules with lower isoelectric points (more carboxyls) will
migrate toward the acidic electrode pole, while those with higher isoelectric
points (more amines) move to the alkaline electrode pole (Egen at al., 1984). In
this experiment, the antimicrobial substance was focused at the lower pH-
range. From this, it was evident that the antimicrobial substance found in MG is
a low molecular weight acidic peptide (Hurst 1981; Delves-Broughton 1990).
The molecular weight of the antimicrobial substance was previously
estimated by gel filtration to be 700 daltons (Al-Zoreky 1988).In the present
study, ultra-filtration showed that the enhancement of the substance in the 1000
MW filtrate was greater than that in either the 5000 MW or the 500 MW filtrate.
The overall decrease in activity from crude MG to the 500 MW filtrate could be
due to losses after each stage of filtering. Since there was no establishment of
activity-units in this experiment, the decrease in overall activity did not
necessarily mean a decrease in specific-activity for each fraction. However, all
active fractions were shown to contain protein.
From all these studies of MG, we believe that the antimicrobial substance
is a low molecular weight (<1000 daltons) acidic peptide that resembles
bacteriocins or, more appropriately, microcins. The presence of organic acids
complicates matters since acetic and propionic acids, as well as diacetyl, could
be inhibitory when present in sufficient concentration (Figure 1.7).However,29
we were able to establish that these organic substances do not contribute
exclusively to the antimicrobial activity of MG (Figure 1.7).Although
propionates do not inhibit Gram-positive bacteria (Internat. Comm. Microbiol.
Spec. Foods, 1980; Barefoot and Nettles 1993), the antimicrobial spectrum of
MG was shown to include both Gram-negative and Gram-positive bacteria. The
inhibitory substance was shown to be thermal stable at low pH ranges and to be
slightly soluble in organic solvent. The thermal stability is similar to bacteriocins
from Lactococcus lactis strains FS 84, FS 90, FS 91-1, and FS 97.The
bacteriocin produced by strain FS 84 demonstrated the greatest stability at pH
4.00 after 2 hours at 100 °C (Muriana, 1993). The thermal stability is also
comparable to some bacteriocins which remain active after heating at 120 °C
for 20 minute (Toba gial., 1991a; Toba gig, 1991b) or 100 °C for 30 minutes
(Joerger and Klaenhammer 1986). The difference in thermal stability could be
attributed to the differences in degree of secondary structure of the bacteriocins.
It could also be due to the specificity of certain amino acids which may include
side chains that are interactive at various pH values (Muriana 1993).The
antimicrobial activity of this peptide is similar to microcin A15, from which a
methionine moiety is released when hydrolysed under mild acid conditions
(Baquero and Moreno 1984).The mechanism of action of microcin A15
involves L-methionine, which inhibits homoserine-O-transsuccinylase, hence
blocking protein synthesis (Baquero and Moreno 1984; Aguilar el g!., 1982).In
addition, the inhibitory activity of crude MG was observed to be enhanced by
sodium citrate salts.200
100
30
--*--Propionic acid
o Acetic acid
20004000 6000 80001000012000
Concentration [ppm]
Figure 1.1Gas-liquid chromatography standard curves for acetic and
propionic acids as determined using 200, 400, 600, 800, 1000, 2000, 4000,
6000, 8000, and 10,000 gg/g of each acid.U-
(4)
31
Figure 1.2Gas-liquid (GC) chromatogram of crude MicrogardTm.GC peaks
were identified as (1) Oxalic acid, (internal standard); retention time=0.39, (2)
acetic acid; retention time=2.07, (3) propionic acid; retention time3.85, (4)
butyric acid; retention time=7.78. Attenuation level for the instrumentwas 8.(2)
(4)
CU
Cs,
(5)
32
1-
CrJ
Figure 1.3Gas-liquid (GC) chromatogram of lyophilized MicrogardTM,pH
5.00. GC peaks were identified as (1) oxalic acid (internal standard); retention
time=0.41, (2) acetic acid; retention time=1.80, (3) propionic acid; retention
time=3.04, (4) isobutyric; retention time=5.21, (5) trimethylacetic acid; retention
time=9.77. Attenuation level for the instrument was 8.33
(2)
Figure 1.4Gas-liquid (GC) chromatogram of ethyl-acetate extract from1000
ultra-filtrate. GC peaks were identified as (1) oxalic acid (internalstandard);
retention time=0.41, (2) acetic acid; retention time=1.82, (3)propionic acid;
retention time=3.11, (4) trimethylacetic acid; retention time=9.85.Attentuation
level for the instrument was 8.34
(2)
Figure 1.5Gas-chromatogram (GC) of MicrogardTM after anion exchange
chromatography. GC peaks were identified as (1) oxalic acid (internal standard)
retention time=0.38; (2) acetic acid; retention time=2.21. No propionic acidwas
detected. Attenuation level for the instrument was 2.35
Figure 1.6Disk assay inhibitory activity againstPseudomonas putidafound
in fractions from crude MicrogardTM. The diameter of inhibition zones were
distinctive in fractions 10°, 1:2, 1:4, 1:8, 1:16, and 1:32.The activity of crude
MicrogardTM used in this experiment was 320 AU/ml.40 33.7
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Figure t7Influence of different purification steps on the inhibitory activity of
MicrogardTM against Pseudomonas putida in relation to amounts of acetic and
propionic acids and diacetyl present after each step.Table 1.1Results of disk assay inhibitory activity against Pseudomonas
putida of lyophilized, MicrogardTM at pH 5.00, 5.30, 6.34, and
8.00.
Zones of inhibition3 (diameter -cm
37
pH5.001 pH5.301 pH 6.34 pH8.002
3.50 cm 3.70 cm 3.70 cm 3.80 cm
1 Crude MicrogardTM adjusted with 10 % tartaric acid to pH 5.00 and 5.30
before lyophilization
2 Crude MicrogardTM adjusted with 0.1 N NaOH solution to pH 8.00
before lyophilization
3 Size of analytical paper disk : 1.30 cm (1/2"); diameter of inhibition zone
measured in cm
4 All samples were resuspended in 0.1 M citrate buffer, pH 5.30 after
lyophilization at the appropriate pHTable 1.2Disk inhibitory activity & total protein assay results with ultra-
filtered MicrogardTM ; inhibition was measured against
Pseudomonas putida
38
Sample Zone of Inhibition, (cm) Total Protein (ug/ml)
Crude MicrogardTM 4.00 NA4
Supernatant 3.60 NA
Pellet 0.00 NA
10000 Mol. Wt Retaintate 1.60 39598.80
10000 Moll. Wt Filtrate2 3.30 1695
5000 Mol. Wt Retaintate 1.50 4050.69
5000 Mol. Wt Filtrate 2.40 1500
1000 Mol. Wt Retaintate 1.60 3247.28
1000 Mol. Wt Filtrate 2.50 1070
500 Mol. Wt Retaintate 1.50 NA
500 Mol. Wt Filtrate 2.30 687
imolecular weight cut-off membranes were supplied by Amicon Co.
Inc.
tall sample were filtered under 30 - 80 psi
3size of analytical paper disk: 1.30 cm; diameter of inhibition zone
measured in cm
4NA denotes not analyzedTable 1.3
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Disk assay inhibitory activity results against Pseudomonas putida
of isoelectric focussed1 (IEF) fractions from 1000 dalton ultra-
filtrate of MicrogardTM
Fractions Ampholyte2-3/10
pH (Control)
Fractionated pH
(Sample)
Inhibition Zone3,4
(cm)
1 2.95 2.21 3.40
2 3.87 3.33 2.70
3 4.30 4.17 1.80
4 4.68 4.40 1.70
5 5.24 4.78 1.55
6 5.46 5.13 1.40
7 6.04 5.61 0.00
8 6.44 6.01 0.00
9 6.74 6.41 0.00
10 7.16 6.76 0.00
1Rotofor fractionator was used for the IEF experiment.
2Commercial ampholyte used was 3/10 (Bio-Rad Laboratories,
Richmond, CA)
3 Size of analytical paper disk: 1.30 cm
4 Diameter of inhibition zone measured in cmTable 1.4
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Disk1 assay inhibitory activity results against Pseudomonas putida
using from ethyl-acetate extracted crude MicrogardTM,1000
molecular cutoff filtrate, and 1% nonfat milk control
Extracted
Fractions2
Crude
MicrogardTM
1K Molecular Wt.
Cut-Off Filtrate
1% Non-Fat Milk
Control
Top 1.703 cm 2.20 cm No Zone of Inhibit.
Middle No Zone of Inhibit.No Zone of Inhibit.No Zone of Inhibit.
Bottom 1.60 cm 1.80 cm No Zone of Inhibit.
1 Size of analytical paper disk- 1.30 cm
2All fractions were purged with nitrogen gas to dryness and then
rehydrated to original volume with 0.1 M citrate buffer (pH 5.30)
3Diameter of inhibition zone measured in cm41
Table 1.5Disk assay inhibitory activity results against Pseudomonas putida
found in ethyl-acetate extracted MicrogardTM
Dilut.
0 1:2 1:4 1:8 1:16 1:32 1:641:1281:2561:5121:10241:2048
Samp
T1142) 2.90 2.50 1.90 1.60 N 13NI NI NI NI NI NI
B12 6.55 3.60 2.50 2.15 1.60 1.50150 1.45 1.40 1.40 1.40 1.40
B 2 6.50 4.50 3.50 2.70 2.35 2.10 2.00 1.50 1.45 1.45 1.45 1.45
B 3 5.75320 2.80 2.10 2.05 1.60150NI NI 1.55 1.60 2.10
B 4 3.30 3.00 2.70250 2.00 1.70155 NI NI 1.60 1.70 2.50
B10 3.60 2.75 2.50 1.75 NI NI NI NI NI NI NI NI
1T denotes top-fraction or organic phase
2 B denotes bottom-fraction or aqueous phase
3 NI denotes non-inhibitory toPseudomonas putida42
Table 1.6Gas-liquid chromatography analysis data for acetic and propionic
acids in lyophilized MicrogardTM
Sample
Acetic acid, Propionic acid,
pg/g % remaining ggig % remaining
Crude MicrogardTm
pH 6.34
4425.82 100 1171.72 100
Lyophilized pH 5.00 1788.00 40.4 508.19 43.4
Lyophilized pH 5.30 2507.60 56.7 724.20 61.8
Lyophilized pH 6.34 3378.44 76.3 873.31 74.5
Lyophilized pH 8.00 3080.77 69.6 793.45 67.7
1 Concentration of organic acids were derived from standard curve
(Figure 1.1)43
Table 1.7Gas-liquid chromatography analysis data for acetic and propionic
acids in ethyl-acetate extracted MicrogardTM (crude)
Sample
Acetic acid, Propionic acid,
1.1g/g% remaining lig/g% remaining
Untreated MicrogardTM 4426 100 1172 100
Ethyl-acetate extracted
MicrogardTM
(top-fraction)
39.12 0.884 21.25 1.813
Ethyl-acetate extracted
MicrogardTM
(middle-fraction)
191.3 4.322 50.65 4.322
Ethyl-acetate extracted
MicrogardTM
(bottom-fraction)
1649 37.26 237.3 20.25
1 Concentration of organic acids were derived from standard curve
(Figure1.1)Table 1.8
44
Gas-liquid chromatography analysis data for acetic and propionic
acids in ethyl-acetate extracted MicrogardTm (1000 MW ultra-
filtrate)
Sample
Acetic acid, Propionic acid1
ilg/g % remaining gg/g % remaining
Untreated MicrogardTM 4426 100 1172
i
100
Ethyl-acetate extracted
1000 ultra-filtrate (F)
top-fraction
40.05 0.905 29.79 2.542
Ethyl-acetate extracted
1000 ultra-filtrate (F)
bottom-fraction
2647.5 59.82 341.4 29.13
1 Concentration of organic acids were derived from standard curve
(Figure1.1)45
Table 1.9Gas-liquid chromatography analysis of ethyl-acetate extracted and
anion exchange treated MicrogardTM
Sample Acetic Acid
(gg/g)
Propionic Acid
(14/g)
Acetic Acid
% Recovery
Propionic Acid
% Recovery
Crude
Microgard
12206.7 5393.16 100 100
10K* (F) B-10 11217.30 2645.40 91.9 49.1
Anion-
Exchange
(active
fraction)
770.00 160.80 6.30 2.98
10K (F) B-10 denotes filtrate of 10,000 daltons, extracted by ethyl-
acetate solvent for a total of 10 times46
Table 1.10Disk assay inhibitory activity results against Pseudomonas putida
found in fractions from initial anion exchange chromatography of MicrogardTM
Fraction # Serial Dilution Zone of Inhibition
(cm)
1 undiluted Nil
2 undiluted NI
3 undiluted NI
4 undiluted 1.45
52 undiluted 1.60
6 undiluted 1.70
1:2 1.45
7 undiluted 1.80
1:2 1.45
8 undiluted 1.80
1:2 1.45
9 undiluted 1.65
1:2 1.40
10 undiluted 1.65
1:2 1.40
11 undiluted 1.60
12 undiluted 1.60
13 undiluted 1.60
14 undiluted 1.55
..
15 undiluted 1.50
16 undiluted 1.50
17 undiluted 1.45
18 undiluted 1.45
19 undiluted NI
20 undiluted NI
1 NI denotes non-inhibitory
2fractions 5 to 16 were combined (6.00 ml), assayed for activity
and passed through a 2nd anion exchange column47
Table 1.11Disk assay inhibitory activity results against Pseudomonas putida
found in the combined active fractions 5 to 16 from anion-
exchange chromatography of MicrogardTm
Serial Dilution Zone of Inhibition
(cm)
10 ° (undiluted) 1.60
Table 1.12Disk assay inhibitory activity results against Pseudomonas putida
found in fractions from 2nd anion-exchange chromatography of
MicrogardTM
Fraction Zone of Inhibition
(cm)
1 NI*
2 1.75
3 1.65
4 NI
5 NI
NI denotes non-inhibitory to the indicator-bacteria48
Table 1.13Activity data for MicrogardTM hydrolyzed at pH 1.00 with respect to
time and temperature. After hydrolysis, samples were adjusted to
pH 5.3 with 1 N HCI and assayed against Pseudomonas putida.
Hydrolysis
Time (min)
50 °C 60 00 70 00 80 00 100 °C 121 °C
0 min 2.65 cm* 3.10 cm 3.30 cm 2.95 cm 2.65 cm 2.15 cm
5 min 2.65 can 3.10 cm 3.30 cm 2.95 cm 2.65 cm 2.15 cm
15 min 2.70 cm 2.90 cm 3.25 cm 3.75 cm 3.80 an 4.40 cm
60 min 3.45 cm 2.95 cm 2.55 cm 2.65 cm 2.90 cm 2.65 cm
Diameter of inhibition zone measured in cm49
Table 1.14Activity data for MicrogardTm hydrolyzed at pH 2.00 with respect to
time and temperature. After hydrolysis, samples were adjusted to
pH 5.3 with 1 N HCI and assayed against Pseudomonas putida.
Hydrolysis
Time (min)
50 °C 60 °C 70 °C 80 C° 100 °C 121 °C
0 min 2.45 cm* 2.10 cm 2.00 cm 2.60 cm 2.00 cm 2.80 cm
5 min 2.45 cm 2.10 cm 2.00 cm 2.60 cm 2.00 cm 2.80 cm
15 min 2.45 cm 235 cm 2.60 cm 2.55 cm 2.60 an 3.10 cm
60 min 2.60 cm 2.80 cm 2.80 cm 3.40 cm 3.00 cm 3.00 cm
Diameter of inhibition zone measured in cm50
Table 1.15Activity data for MicrogardTm hydrolyzed at pH 3.00 with respect to
time and temperature. After hydrolysis, samples were adjusted to
pH 5.3 with 1 N HCI and assayed against Pseudomonas putida.
Hydrolysis
Time (min)
50 °C 60 °C 70 °C 80 °C 100 °C 121 °C
0 min 2.65 cm' 2.95 cm 3.35 cm 3.15 cm NI2 NI
5 min 2.60 cm 2.90 cm 3.30 cm 3.10 cm NI2 NI
15 min 3.00 can 3.15 cm 3.40 cm 3.15 cm 3.10 cm 3.30 cm
60 min 2.10 cm 3.05 cm 2.00 cm 1.50 cm 150 cm 1.50 cm
1 Diameter of inhibition zone measured in cm
2 NI denotes non-inhibitory to the indicator-bacteria51
Table 1.16Activity data for MicrogardTM hydrolyzed at pH 4.00 with respect to
time and temperature. After hydrolysis, samples were adjusted to
pH 5.3 with 1 N HCI and assayed against Pseudomonas putida.
Hydrolysis
Time (min)
50 °C 60 °C 70 °C 80 °C 100 °C 121 °C
0 min NI2
.
2.10 cm1 2.20 cm 2.90 cm
,
335 can 2.45 cm
5 min N I 2.10 cm 2.20 cm 2.90 cm 3.35 cm 2.45 cm
15 min 3.40 an 3.65 cm 3.65 cm 4.80 cm 5.40 cm 4.10 cm
60 min 2.70 cm 3.15 cm 2.35 cm 2.20 an 2.60 cm 2.50 cm
1 Diameter of inhibition zone measured in cm
2 NI denotes non-inhibitory to the indicator-bacteria52
Table 1.17Activity data for MicrogardTM hydrolyzed at pH 9.00 with respect to
time and temperature. After hydrolysis, samples were adjusted to
pH 5.3 with 1 N HCI and assayed against Pseudomonas putida.
Hydrolysis
Time (min)
50 °C 60 °C 70 °C 80°C 100 °C 121 °C
0 min 1.70 cm* 1.75 cm 1.70 cm 2.10 cm 1.65 cm 1.90 cm
5 min 1.70 cm 1.75 cm 1.70 cm 2.10 cm 1.65 cm 1.90 cm
15 min 1.60 cm 1.80 cm 1.80 cm 1.75 cm 1.90 cm 2.00 cm
60 min 1.60 cm 1.60 cm 1.60 cm 1.60 cm 1.60 cm 1.60 cm
Diameter of inhibition measured in cm53
Table 1.18Activity data for MicrogardTM hydrolyzed at pH 10.00 with respect
to time and temperature. After hydrolysis, samples were adjusted
to pH 5.3 with 1 N HCI and assayed against Pseudomonas putida.
Hydrolysis
Time (min)
50 °C 60 °C 70 °C 80 °C 100 °C 121 °C
0 min 2.20 cm* 2.20 cm 2.20 cm 2.20 cm 220 cm 1.80 cm
5 min 220 cm 2.20 cm 2.20 cm 2.20 cm 2.20 an 1.80 cm
15 min 2.10 cm 2.00 cm 2.10 cm 1.60 cm 1.65 cm 1.90 cm
60 min 1.65 cm 1.70 cm 1.70 cm 1.70 cm 1.70 cm 1.70 cm
Diameter of inhibition zone measured in cm54
Table 1.19Activity data for MicrogardTM hydrolyzed at pH 11.00 with respect
to time and temperature. After hydrolysis, samples were adjusted
to pH 5.3 with 1 N HCI and assayed against Pseudomonas putida.
Hydrolysis
Time (min)
50 °C 60 °C 70 °C 80 °C 100°C 121 °C
0 min 2.40 cm* 1.95 cm 1.90 cm 1.80 cm 2.00 cm 1.65 cm
5 min 240 cm 1.95 cm 1.90 cm 1.80 cm 2.00 cm 1.65 cm
15 min 1.80 cm 1.80 cm 1.80 cm 1.85 cm 2.10 cm 2.15 cm
60 min 1.85 cm 1.80 cm 1.60 cm 1.60 cm 1.60 cm 1.60 cm
Diameter of inhibition zone measured in cm55
Table 1.20Activity data for MicrogardTM hydrolyzed at pH 12.00 with respect
to time and temperature. After hydrolysis, samples were adjusted
to pH 5.3 with 1 N HCI and assayed against Pseudomonas putida.
Hydrolysis
Time (min)
50 °C 60 °C 70 °C 80 °C 100 °C 121 °C
0 min 1.75 cm* 1.80 cm 1.75 cm 2.00 cm 1.80 cm 2.45 cm
5 min 1.75 cm 1.80 cm 1.75 cm 2.00 cm 1.80 cm 2.45 cm
15 min 1.65 cm 1.65 cm 1.85 cm 1.85 cm 1.85 cm 1.90 cm
60 min 1.65 cm 1.70 cm 1.70 cm 1.70 cm 1.85 cm 1.90 cm
Diameter of inhibition zone measured in cm56
REFERENCES
Abdel-Bar, N., N. D. Harris, and R. L. Rill. 1987. Purification and properties of an
antimicrobial substance produced by Lactobacillus bulgaricus. J. Food Sci.
52:411-415.
Aguilar, A., J. C. Perez-Diaz, F. Baquero, and C. Asensio. 1982. Microcin 15m
from Escherichia coli : Mechanism of antibiotic action. Antimicrob. Agents
and Chemother. 21:381-386.
Al-Zoreky, N. 1988. Microbiological control of food spoilage and pathogenic
microorganisms in refrigerated foods. M.S. thesis. Oregon State University.
Corvallis.
Al-Zoreky, N., J. W. Ayres and W. E. Sandine. 1991. Antimicrobial activity of
MicrogardTM against food spoilage and pathogenic microorganisms. J.
Dairy Sci. 74:758-763.
Anderson, T. M., E. A. Bodie, N. Goodman, and R. D. Schwartz. 1986. Inhibitory
effect of autoclaving whey-based medium on propionic acid production by
Propionibacterium shermanii. Appl. Environ. Microbiol. 51(2):427-428.
Asensio, C., J. C. Perez-Diaz, M. C. Martinez, and F. Baquero. 1976. A new
family of low molecular weight antibiotics from enterobacteria. Biochem.
Biophys. Res. Commun. 69:7-14.
Ayres, J. W., W. E. Sandine, and G. H. Weber, inventors. 1987. Propionates and
metabolites of propionibacteria affecting microbial growth. Canadian
Patent No. 1218894. March 10. Oregon State Univ., Corvallis, assignee.
Baird-Parker, A. C. 1980. Organic Acids, p. 126-135. In J.H. Silliker, R.P. Elliott,
A.C. Baird-Parker, F.L. Bryan, J.H.B. Christian, D.S. Clark, J.C. Olson, Jr.,
and T.R. Roberts (ed.), Microbial ecology of foods, vol. 1: factors affecting
life and death of microorganisms. Academic Press, New York.
Baquero, F., and C. Asensio. 1979. Microcins as ecological effectors in human
intestinal flora: preliminary findings, p. 90-94. In D. van der Waaij and J.
Verhoef (ed.) New criteria for antimicrobial therapy: maintenance of
digestive tract colonization resistance. Excerpta Medica. Amsterdam.
Baquero, F., and F. Moreno. 1984. The microcins. FEMS Microbiol. Lett. 23:117-
124.
Barefoot, S. F., and T. R. Klaenhammer. 1983. Detection and activity of Lactacin
B, a bacteriocin produced by Lactobacillus acidophilus. Appl. Environ.
Microbiol. 45:1808-1815.57
Barefoot, S. F., and T. R. Klaenhammer. 1984. Purification and characterization
of the Lactobacillus acidophilus bacteriocin Lactacin B. Antimicrob. Agents
Chemother. 26:328-334.
Barefoot, S. F., and C. G. Nettles. 1993. Antibiosis revisited: bacteriocins
produced by dairy starter cultures. J. Dairy Sci. 76:2366-2379.
Basler, A. W., V. Der Nude, and M. Scheutwinkel. 1987. Screening of food
additive propionic acid for genotoxic properties. Fd. Chem. Toxic.
25(4):287-290.
Biede, S. L., and E. G. Hammond. 1979. Swiss cheese flavor. II. Organoleptic
analysis. J. Dairy Sci. 62:238-248.
Blanc, P., and G. Goma. 1987. Kinetics of inhibition in propionic acid
fermentation. Bioproc. Eng. 2:175.
Blanc, P., and G. Goma. 1987. Propionic acid fermentation: Improving of
performances by coupling continuous fermentation and ultra-filtration.
Bioproc. Eng. 2:137.
Bodie, E. A., T. M. Anderson, N. Goodman, and R. D. Schwartz. 1987. Propionic
acid fermentation of ultra-high-temperature sterilized whey using mono-
and mixed-cultures. Appl. Microbiol. Biotechnol. 25:434.
Border, P. M., M. P. J. Kierstan, and G. S. Plastow. 1987. Production of propionic
acid by mixed bacterial fermentation. Biotechnol. Lett. 9:843.
Boyaval, P., and C. Corres. 1987. Continuous fermentation of sweet whey
permeate for propionic acid production in a CSTR with OF recycle.
Biotechnol. Lett. 9:801.
Branen, A. L., H. C. Go and R. P. Genske. 1975. Purification and Properties of
Antimicrobial Substances Produced By Streptococcus diacetilactis and
Leuconostoc citrovorum. J. Food Sci. 40:446-450.
Brock, J. H., 1980. Lactoferrin in human milk: its role in iron absorption and
protection against enteric infecfion in newborn infant.Arch. Dis. Child.
55:417.
Bryant, F., and B. T. Overell. 1953. Quantitative chromatographic analysis of
organic acids in plant tissue extracts. Biochem. et Biophy. Acta 10:471-
476.
Bulgarelli, M. A., and L. A. Shelef. 1985. Effect of EDTA on growth for spores of
Bacillus cereus. J. Food Sci. 50(3):661-664.
Bullen, J. J. 1981. The significant of iron in infection. Rev. Infect. Dis. 3:1127.58
Bullen, J. J., H. J Rogers, and L. Leigh. 1972. Iron-binding protein in milk and
resistance to E. coli infection in infants. Br. Med. J. 1:69.
Calvin, J. F., C. Saint, and C. Divies. 1985. Continuous production of Emmental
cheese flavours and propionic acid starters by immbilized cells ofa
propionic acid bacterium. Biotechnol. Lett. 7:821.
Clausen, E. C., and J. L. Gaddy. 1981. Fermentation of biomass into acetic and
propionic acids with Propionibacterium acidi-propionici. p.63 In: M. Moo-
Young and C.W. Robinson, (ed.), Advances in Biotechnology, vol. 2.
Pergamon, Toronto.
Crespo, J. P. S. G., M. J. Moura, M. J. T. Carrondo. 1990. Some engineering
parameters for propionic acid fermentation coupled with ultrafiltration.
Appl. Biochem. Biotechnol. 24/25:613-625.
Crow, V. L. 1987. Citrate cycle intermediates in the metabolism of aspartate and
lactate by Propionibacterium freudenreichii subsp. shermanii. Appl.
Environ. Microbiol. 53(10):2600-2602.
Crow, V. L., and K. W. Turner.1986. The effect of succinate productionon other
fermentation products in Swiss-type cheese. New Zealand J. Dairy Sci.
and Technol. 21:217-227.
Daeschel, M. A., and T. R. Klaenhammer. 1985. Association ofa 13.6
megadalton plasmid in Pediococcus pentosaceus with bacteriocin activity.
Appl. Environ. Microbiol. 50:1538-1541.
Daeschel, M. A. 1989. Antimicrobial substances from lactic acid bacteria foruse
as food preservatives. Food Technol. 43:164-166.
Datta, R. 1981. Acidogenic fermentation of corn stover. Biotechnol. Bioeng.
23:1.
Davey, G. P., and B. C. Richardson. 1981. Purification andsome properties of
diplococcin from Streptococcus cremoris 346. Appl. Environ. Microbiol.
41:84-89
Delves-Broughton, J. 1990. Nisin and its uses a food preservative. Food
Technol. 100-117.
Drucker, D. B. 1981. Microbiological application of gas chromatography.
Cambridge Unversity Press, Cambridge, United Kingdom.
Dumont, J-P., and J. Adda. 1978. Occurence of sesquiterpenes in Mountain
cheese volatiles. J. Agr. Fod Chem. 26(2):364-367.
Egen, N. B., W. Thormann, G. E. Twitty, and M. Bier. 1984. Electrophoresis'83,
p.547-550. In Hirai, H., (ed.), de Gruyeter, W., Berlin.59
Emde, R. and B. Schinck. 1990. Enhanced propionate formation by
Propionibacterium freudenreichii subsp. shermanii in a three-electrode
amperometric culture system. Appl. Environ. Microbiol. 56:2771-2776.
Ersfeld-Dressen, H., H.-G. Sahl, and H. Brandis. 1984. Plasmid involvement in
production of and immunity to the staphylococcin-like peptide Pep 5. J.
Microbial. 130:3029-3035.
Fitzgerald, G. F.,E. E. Vaughan, and C. Daly,. 1992. Identification and
characterization of Helveticin V-1829, a bacteriocin produced by
Lactobacillus helveticus 1829. J. Appl. Bacteriol. 73:299-308.
Fleming, H. P., J. L. Etchells, and R. N. Costilow. 1975. Microbial inhibition by an
isolate of Pediococcus from cucumber brines. Appl. Microbiol. 30:1040-
1042.
Fujimura, S., and T. Nakamura. 1978. Purification and properties of a
bacteriocin-like substance (acnecin) of oral Propionibacterium acnes.
Antimicrob. Agents Chemother. 14:893-898.
Garcia-Bustos, J. F., N. Pezzi, and C. Asensio. 1984. Microcin 7: Purification and
properties. Biochem. Biophy. Res. Comm. 119:779-785.
Gilliand, S. E., and M. L. Speck 1974. Inhibition of psychotrophic bacteria by
lactic acid bacteria in nonfermented refrigerated foods. Paper presented at
the 34th Annual IFT Meeting, New Orleans, May 12-15.
Glatz, B. A. 1992. The classical propionibacteria: Their past, present, and future
as industrial organisms. ASM News. 58:197-201.
Gonzales, C. F. 1989. Method for inhibiting bacterial spoilage and resulting
compositions. US Patent 4,883,673.
Gonzales, C. F., and B. S. Kunka. 1987. Plasmid-associated bacteriocin
production and sucrose fermentation in Pediococcus acidilactici. Appl.
Environ. Microbiol. 53:2534-2538.
Grinstead, D. A., and S. F. Barefoot. 1992. Jensenii G, a heat-stable bacteriocin
produced by Propionibacterium jensenii P126. Appl. Environ. Microbiol.
58:215-220.
Gross, E., and Morell, J.L. 1971. The structure of nisin. J. Am. Chem. Soc.
93:4634-4637.
Guomundsdottir, A., G. Stoffels, and I. F. Nes.1992. Isolation and properties of a
bacteriocin-producing Carnobacterium piscicola isolated from fish. J. Appl.
Bacteriol. 73:309-316.60
Hale, E. M., and R. D. Hinsdill. 1973. Characterization of a bacteriocin from
Staphylococcus aureus strain 462. Antimicrob. Agents and Chemother.
4:634-640.
Hechard, Y., B. Derijard, F. Letelier, and Y. Cenatiempo. 1992. Characterization
and purification of Mesentericin Y105, an anti-listeria bacteriocin from
Leuconostoc mesenteroides. J. Gen. Microbiol. 138:2725-2731.
Henderson, J. T., A. L. Chopko, and P. D. van Wassenaar. 1992. Purification
and primary structure of Pediocin PA-1 produced by Pediococcus
acidilactici PAC-1.0. Arch. Biochem. Biophy. 295:5-12.
Herrero, A. A. 1983. End-product inhibition in anaerobic fermentation. Trends in
Biotechnol. 1:49.
Hettinga D. H., and G. W. Reinbold 1972a. The Propionic-acid bacteriaa
review. I. Growth. J. Milk Food Technol. 35:295-301.
Hettinga D. H., and G. W. Reinbold 1972b. The Propionic-acid bacteriaa
review. II. Metabolism. J. Milk Food Technol. 35:358-372.
Hettinga D. H., and G. W. Reinbold 1972c. The Propionic-acid bacteriaa
review.Ill. Miscellaneous metabolic activities. J. Milk Food Technol.
35:436-447.
Hill, C., and E. Parente. 1992. Characterization of Enterocin 1146, a bacteriocin
from Enterococcus faecium inhibitory to Listeria monocytogenes. J. Food
Prot. 55:497-502.
Hitchner, E. R. 1934. some physiological characteristics of propionic-acid
bacteria. J. Bacteriol. 28:473-479.
Hoick, A., L. Axelsson, S.-E. Birkeland, T. Aukrust, and H. Blom. 1992.
Purification and amino acid sequence of Sakacin A, a bacteriocin from
Lactobacillus sake LB706. J. Gen. Microbiol. 138:2715-2720.
Horner, T., H. Zahner, R. Kellner, and G. Jung. 1989. Fermentation and isola-
tion of epidermin, a lanthionine containing polypeptide antibiotic from
Staphylococcus aureus. Appl. Microbiol. and Biotechnol. 30:219-225.
Hsu, S.-T., and S.-T. Yang. 1991. Propionic acid fermentation of lactose by
Propionibacterium acidipropionici :Effects of pH. J. Biotech. Bioeng.
38:571-578.
Hurst, A. 1966. Biosynthesis of the antibiotic nisin and other basic peptides by
Streptococcus lactis grown in batch culture. J. Gen. Microbiol. 45:503-513.
Hurst, A. 1981. Nisin. Adv. Appl. Microbiol. 27:85-123.61
Hurst, A. and G. J. Dring. 1968.The relation of length of lag phaseof growth to the synthesis of nisin andother basic proteins byStreptococcus lactis
grown under different cultural conditions.J. Gen. Microbial. 50:383-390.
Ibragimova, S. I., N. M. Neronova,and I. L. Rabotbova. 1969. Kineticof growth inhibition in Propionibacteriumshermanii by hydrogen and hydroxylions. Mikrobiologiya. 38:933.
International Committeeon Microbiological Specificationson Foods. 1980.
Organic acids. p. 126 In MicrobialEcology of Foods. vol. 1. Academic
Press. New York, N.Y.
Jay, J. M. 1982. Antimicrobialproperties of diacetyl. Appl. Environ.Microbiol. 44:525-532.
Jimenez-Diaz, R., R. M. Rios-Sanchez,M. Desmazeaud, J. L. Ruiz-Barba,and J.-C. Piard. 1993. Plantaricins Sand T, two new bacteriocinsproduced by
Lactobacillus plantarum LPC010isolated from a green olivefermentation. Appl. Environ. Microbiol. 59:1416-1424.
Joerger, M. C., and T. R. Klaenhammer.1986. Characterization andpurification of Helveticin J. and evidencefor a chromosomally determinedbacteriocin produced by Lactobacillus helveticus481. J. Bacteriol. 167:439-446.
Kabara, J. J. 1978. Fatty acidsand derivatives as antimicrobialagents- A review. Ch. 1 In "The pharmacologicaleffects of lipids," Jon J. Kabara,ed., American Oil Chem. Soc., Champaign,IL.
Kato, F., Y. Eguchi, M. Nakano,T. Oshima, and A. Murata.1991. Purification and
Characterization of Linecin A,a Bacteriocin of Brevibacterium linens.J. Agric. Biol. Chem. 55:161-166.
Konishi, Y., S. K. Jun-ichi Kurisaki,and K. Yamanchi. 1985.Detection of antigenicity by radioimmune-assayand of trypsin inhibitory activityin heat
or enzyme denatured ovomucoid. J. FoodSci. 50(5)1 422-1426.
Konisky, J. 1982. Colicins andother bacteriocins with establishedmodes of
action. Ann. Rev. Microbial. 36:125.
Kordel, M., F. Schuller, and H-G. Sahl.1989. Interaction of thepore forming-
peptide antibiotics Pep 5, nisinand subtilin with non-energizedliposomes. J. Fed. Eur. Biochem. Soc.Lett. 244:99-102.
Kordel, M., and H-G, Sahl.1986. Susceptibility of bacterial,eukaryotic and
artificial membranes to the disruptiveaction of the cationic peptides Pep5 and nisin. FEMS Microb. Lett.34:139-144.62
Langsrud, T., and G. W. Reinbold. 1973a. Flavor development and microbiology
of Swiss cheese-a review.II.Starters, manufacturing processes and
procedures. J. Milk Food Technol. 36:531-542.
Langsrud, T., and G. W. Reinbold. 1973b. Flavor development and microbiology
of Swiss cheese-a review. III. Ripening and flavor production. J. Milk Food
Technol. 36:593-609.
Lee, S. Y., E. R. Vedamuthu, C. J. Washam, and G. W. Reinbold. 1970. Diacetyl
production by Propionibacterium shermaniiin milk cultures. Can. J.
Microbiol. 16:1231-1242.
Lewis, P.V., and S.-T. Yang. 1992. Propionic acid fermentation by
Propionibacterium acidipropionici :Effect of growth substrate.Appl.
Microbiol. Biotechnol. 37: 437-442.
Lewis, P. V., 1991. A novel extractive fermentation process for propionic acid
production from lactose using an immobilized cell bioreactor. M.S. thesis,
Ohio State University, Columbus.
Lozano, J. C. N.,J. Nissen-Meyer, K. Sletten, C. Pelaz, and I. F. Nes. 1992.
Purification and amino acid sequence of a bacteriocin produced by
Pediococcus acidilactici. J. Gen. Microbiol. 138:1985-1990.
Lyon, W. J., and B. A. Glatz. 1991. Partial purification and characterization of a
bacteriocin produced by Propionibacterium thoenii. Appl. Environ.
Microbiol. 57:701-706.
Lyon, W. J., J. K. Sethi, and B. A Glatz. 1993. Inhibition of psychrotrophic
organisms byPropionicinPLG-1abacteriocinproducedby
Propionibacterium thoenii. J. Dairy Sci. 76: 1506-1513.
Marwaha, S. S., R. P. Sethi, and J. F. Kennedy. 1983. Role of amino acids,
betaine and cholineinvitamin B12 biosynthesis by strainsof
Propionibacterium. Enzyme and Microbial Technol. 5(6):454-465.
Mathieu, F., I. S. Suwandhi, N. Rekhif, J. B. Milliere, and G. Lefebvre. 1993.
Mesenterocin 52, a bacteriocin produced by Leuconostoc mesenteroides
ssp. mesenteriodes FR 52. J. Appl. Bacteriol. 74:372-379.
Mitruka, B. M. 1975. Gas chromatography applications in microbiology and
medicine. John and Wiley & Sons, Inc., New York.
Mortvedt, C. I., J. Nissen-Meyer, K. Sletten, and I. F. Nes. 1991. Purification and
amino acid sequence of Lactocin S, a bacteriocin produced by
Lactobacillus sake L45. Appl. Environ. Microbiol. 57:1829-1834.63
Muriana, P. M., and T. R. Klaenhammer. 1991. Purification and partial
characterization of Lactacin F, a bacteriocin produced by Lactobacillus
acidophilus 11088. Appl. Environ. Microbiol. 57:114-121.
Muriana, P. M. 1993. Antimicrobial peptides and their relation to food quality. p.
303-321, Ch. 24 In "Food Flavor and Safety." American Chemical Society,
Washington, D.C.
Neronova, N. M., S.I. Ibragimova, N. D. lerussalimskii. 1967. Effect of the
propionate concentration on the specific growth rate of Propionibacterium
shermanii. Mikrobiologiya 36:404.
Paul, G. E., and S. J. Booth. 1988. Properties and characteristics of a
bacteriocin-like substance produced by Propionibacterium acnes isolated
from dental plaque. Can. J. Microbiol. 34:1344-1347.
Perez-Mendoza, J. L., and F. Garcia-Hernandez. 1983. Fermentation of a
waste- product from industrial processing of lime (Citrus aurantifolia
Swingle) for vitamin B12 production. Biotechnol. Lett. 5(4):259-264.
Perlman, D. 1978. Vitamins, p.303-326. In A.H. Rose (ed.), Economic
microbiology, vol. 2. Primary products of metabolism. Academic Press, Inc.,
London.
Piard, J. C., P. M. Muriana, M. J. Desmazeaud and T. R. Klaenhammer. 1992.
Purification and partial characterization of Lacticin 481, a lanthionine-
containing bacteriocin produced by Lactococcus lactis subsp./actis CNRZ
481. Appl. Environ. Microbiol. 58:279-284.
Pulusani, S. R., D. R. Rao and G. R. Sunki. 1979. Antimicrobial activity of lactic
cultures:Partialpurification and characterization of antimicrobial
compound(s) produced by Streptococcus thermophilus. J. Food Sci.
44:575-578.
Ramanathan, S., C. Wolynec, and W. Cutting. 1968. Antiviral principles of
propionibacteria-isolation and antiviral activity of propionins B and C. Proc.
Soc. Exp. Biol. Med. 129:73-77.
Ramanathan, S., G. Read, and W. Cutting. 1966. Purification of propionin, an
antiviral agent from propionibacteria. Proc. Soc. Exp. Biol. Med. 123:271-
273.
Reddy, N. S., K. M. Shahani, B. A. Friend, and R. C. Chandran. 1983. Natural
antibiotic activity of Lactobacillus acidophilus and bulgaricus :III:
Production and partial purification ofbulgarican from Lactobacillus
bulgaricus. Cult. Dairy Prod. J. 18:15.
Rehberger, T. G., and B. A. Glatz. 1990. Characterization of propionibacterium
plasmids. Appl. Environ. Microbiol. 56:864-871.64
Ro, S. L., M. Woodburn, and W. E. Sandine. 1979. Vitamin B12 and ascorbic
acid in Kimchi inoculated with Propionibacteriumfreudenreichii subsp.
shermanii. J. Food Sci. 44:873-877.
Roller, S. 1991. The biotechnological development of new food preservatives.
Biotechnol. and Gen. Engin. Rev. 9:183-206.
Sahl, H.-G. 1985. Bactericidal cationic peptides involvedinbacterial
antagonism and host defence. Microbiol. Sci. 2(7):212-217.
Saito, H., H. Miyakawa, Y. Tamura, S. Shimamura, and M. Tomita. 1991. Potent
bactericidal activity of bovine lactoferrin hydrolysate produced by heat
treatment at acidic pH. J. Dairy Sci. 74:3724-3730.
Salih, M. A., and W. E. Sandine. 1990. Inhibitory Effects of MicrogardTm on
yogurt and cottage cheese spoilage organisms. J. Dairy Sci. 73:887-893.
Sandine, W. E., J. Ayres, and G. Weber, inventors. 1992. Preserving foods using
metabolites of propionibacteria other than propionic acid. U.S. Patent No.
5096718. March 17. Oregon State Univ., Corvallis, assignee.
Schales, Otto. 1951. Effect of albumin on the antibacterial activity of diketones.
Arch. Biochem. Biophys. 34:56-63.
Shahani, K. M., J.F. Vakil, and A. Kilara. 1976. Natural antibiotic activity of
Lactobacillus acidophilus and bulgaricus. Cult. Dairy Prod. J. 11:14
Shahani, K. M., J. F. Vakil, and A. Kilara. 1977. Natural antibiotic activity of
Lactobacillus acidophilus and bulgaricus. 2. Isolation of Acidophilin from L.
acidophilus. Cult. Dairy Prod. J. 12:8.
Shibasaki, I., and N. Kato. 1978. Combined effect on antibacterial activity of fatty
acids and their esters against gram negative bacteria. Ch. 2 In "The
Pharmacological effects of lipids." J.J. Kabara ed., America Oil Chem. Soc.
Champaign, IL.
Silva, M., N. W. Jacobus, C. Deneke and S. L. Gorbach. 1987. Antimicrobial
substance from a human Lactobacillus strain. Antimicrob. Agents
Chemother. 31:1231-1233.
Siragusa, G. R., and C. N. Cutter. 1993. Brochocin-C, a new bacteriocin
produced by Brochothrix campestris. Appl. Environ. Microbiol. 59:2326-
2328.
Stevens, K. A., B. W. Sheldon, N. A. Klapes, and T. R. Klaenhammer. 1991.
Nisin treatment for inactivation of Salmonella species and other Gram-
negative bacteria. Appl. Environ. Microbiol. 57:3613-3615.65
Stevens, K. A., B. W. Sheldon, N. A. Klapes, and T. R. Klaenhammer. 1992a.
Effect of treatment conditions on nisin inactivation of Gram-negative
bacteria. J. Food Prot. 55:763-766.
Stevens, K. A., N. A. Klapes, B. W. Sheldon, and T. Klaenhammer. 1992b.
Antimicrobial actionofnisinagainst Salmonella typhimurium
lipopolysaccharide mutants. Appl. Environ. Microbiol. 58:1786-1788.
Stoffels, G., J. Nissen-Meyer, A. Gudmundsdottir, K. Sletten, H. Ho lo, and I. F.
Nes. 1992. Purification and characterization of a new bacteriocin isolated
from a Carnobacterium sp. Appl. Environ. Microbiol. 58:1417-1422.
Tagg, J. R., A. S. Dajani, and L. W. Wannamaker. 1976. Bacteriocins of Gram-
positive bacteria. Bacteriol. Rev. 40:722-756.
Tahara, T., K. Kanatani, K. Yoshida, H. Miura, M. Sakamoto, and M. Oshimura.
1992. Purification and some properties of Acidocin 8912, a novel
bacteriocin produced by Lactobacillus acidophilus TK8912. Biosci.
Biotech. Biochem. 56:1212-1215.
Tang, I-C., M. R. Okos, and S.-T. Yang. 1989. Effects of pH and acetic acid on
homoacetic fermentation of lactate by Clostridium formicoaceticum.
Biotech. and Bioengin. 34:1063-1074.
Thomas, T. D. 1987. Acetate production from lactate and citrate by non-starter
bacteria in cheddar cheese. New Zealand J. Dairy Sci. and Technol.
22:25-38.
Thornhill, Patrick J., and Timothy M. Cogan. 1984. Use of gas-liquid
chromatography to determine the end products of growth of lactic acid
bacteria. Appl. Environ. Microbiol. 47:1250-1254.
Toba, T., S. K. Samant, E. Yoshioka, and T. Itoh. 1991b. Reutericin 6, a new
bacteriocin produced by Lactobacillus reuteri LA 6. Letts. Appl. Microbiol.
13:281-286.
Toba, T., E. Yoshioka, and T. Itoh. 1991a. Potential of Lactobacillus gasseri
isolated from infant faeces to produce bacteriocin. Letts. Appl. Microbiol.
12:228-231.
Tomita, M., W. Bellamy, M. Takase, K. Yamauchi, H. Wakabayashi, and K.
Kawase. 1991. Potent antibacterial peptides generated by pepsin
digestion of bovine lactoferrin. J. Dairy Sci. 74:4137-4142.66
Torreblanca, M., I. Meseguer, and F. Rodriguez-Valera.1989. Halocin H6, a
bacteriocin from Haloferax gibbonsii. J. Gen. Microbiol. 135:2655-2661.
Marcoux, V., Y. Beaulieu, C. P. Champagne, and J. Goulet. Production of
Propionibacterium freudenreichii subsp. shermanii in Whey-Based Media.
J. Ferm. and Bioeng. 74: 95-99.
Vorob'eva, L. I., S. Al'-Sudani, and N. I. Kraeva. 1987. Peroxidase of propionic
acid bacteria. Microbiol. 56(4):590-593.
Weber, G. H., and W. A. Broich. 1986. Shelf life extension of cultured dairy
foods. Cultured Dairy Products J. 21(4):19-23.
Whitehead, H. R. 1933. A substance inhibiting bacterial growth by certain
strains of lactic streptococci. Biochem. J. 27:1793-1800.67
CHAPTER 2
PURIFICATION OF A BACTERIOCIN FROM MICROGARDTM
ABSTRACT
The bacteriocin in crude MicrogardTM (MG) was isolated and purified to
homogeneity by reverse-phase high performance liquid chromatography.
Acetic and propionic acids present were successfully removed by a strong
anion exchanger.Isolation of the antimicrobial substance involved ultra-
filtration and gel filtration. The bacteriocin was found to be most active in the
filtrate from the 1000 molecular weight cut-off membrane (< 1000 daltons). The
500 molecular weight cut-off retaintate was found to be more inhibitory when
compared to other retaintates. The molecular weight of the bacteriocin was
estimated to be 860 daltons by gel filtration.Data from mass spectroscopy
showed two peaks that are in a series, 295 and 441.7 suggesting charges of 3
(MH+3) and 2 (MH+2), respectively. The molecular weight determined by mass
spectroscopy was 881.7 daltons.Amino-acid analysis by Edman degradation
method confirmed that it is a peptide consisting of 4 residues of methionine, 2 of
valine, 1 of glutamic acid, and possibly 1 of glycine. The molecular weight by
this process was estimated to be 926 daltons. The psychotrophic bacterium
Pseudomonas putida ATCC 12633 was sensitive to all partial and fully
purified fractions of MG.The final product from high performance liquid
chromatography was stable when stored at -40 0C in sodium acetate buffer (pH
5.3).68
INTRODUCTION
Bacteriocins are an extremely heterogeneous group of substances. The
original definition of bacteriocins referred to proteins of the colicin type
produced by Escherichia coil (Jacob at al., 1953).Produced by strains of
Gram-positive and Gram-negative bacteria, they were characterized by lethal
biosynthesis, intraspecific activity, and adsorption to specific receptors (Tagg gl
al., 1976). Tagg gal. (1976) defined bacteriocins as active macromolecules
possessing a narrow inhibitory spectrum of activity, protein in nature, plasmid
encoded and without effect on producer cells. Reports have shown that, unlike
most bacteriocins produced by Gram-negative bacteria which act on closely
related species, bacteriocins from Gram-positive bacteria have been shown
also to inhibit Gram-negative organisms (Wolff and Duncan 1974; Silva gi al.,
1987; Brunia gl at, 1988; Lyon and Glatz 1991; Lewus a al., 1991). On the
other hand, Klaenhammer (1988) pointed out that inhibition of Gram-negative
bacteria has not been clearly demonstrated by purified bacteriocins from Gram-
positive organisms.In this regard, the presence of a lipoteichoic acid receptor
for pediocin AcH in the host cell wall suggested that the bacteriocins from Gram-
positive bacteria may not be inhibitory to Gram-negative organisms since they
do not possess cell wall teichoic acid (Bhunia gt at., 1991).
Many strains of Gram-positive fermentation starter culture bacteria
produce bacteriocins such asNisin,Diplococcin, Leuconocin Lcm,
Mesenteroicin 5, Pediocin AcH, Pediocin PA1, Pediocin A, Lactacin A, Lactacin
F, Acidophilucin A, Plantacin B, Plantaricin A, Lacticin, Lactocin 27, Helveticin J,
Brevicin 37, Sakacin A, Lactocin S, Bifidin, and Propionicin PLG-1 (Ray and
Daeschel 1992). These bacteriocins possess narrow or wide spectra of activity.
However, it is those with the wider range of activity that are desirable as food69
biopreservatives.Characteristics that defined abacteriocin have been
expanded to include their chemical nature, stability, mode of action, genetic
determination, inhibitory spectrum, sensitivity to various proteases, mode of
synthesis, and toxicity level to animals (Ray and Daeschel 1992).The
molecular weights of bacteriocins also vary greatly. They have been classified
into small or large molecular-weight groups.In general, low molecular weight
bacteriocins are sensitive to trypsin digestion but insensitive to heat inactivation
(Bradley 1967). Caseicin 80, a large bacteriocin is produced by Lactobacillus
casei and has a molecular weight of 40,000 daltons (Rammelsberg and Radler
1990). A well characterized low molecular weight bacteriocin (2500 daltons) is
produced by Lactobacillus acidophilus (Muriana and Klaenhammer 1991).
Another group of amino acid-peptide antimetabolites of low molecular
weight (< 5000 daltons) produced by enterobacteria has been reported.
Microcin C7 is a bacteriostatic antibiotic of about 900 daltons in size.It is
resistant to heat treatment (100 0C, 30 minutes) but sensitive to trypsin and
subtilisin (Baquero and Moreno 1984).Amino acid analysis of Microcin C7
showed a linear octapeptide of moderate polarity.The structure consists of
acetyl-methonine, arginine, threonine, glycine, asparagine, and alanine with an
ethanolamine at its carboxyl terminus. Microcin D140 (-500 daltons) is a highly
hydrophilic basic peptide with sensitivity to trypsin and subtilisin (Garcia-Busto
1984). The spectrum of activity of these microcins includes inhibition for
Escherichia spp. Salmonella spp., Shigella spp., Citrobacter spp., Klebsiella
spp., and Enterobacter spp. However, Pseudomonas spp. and Acinetobacter
spp. are resistant (Baquero and Moreno 1984).
In the United States, nisin is the only bacteriocin that is permitted to be
incorporated into food systems (Anonymous 1988).It was first recognized and
characterized by Rogers and Whittier (1928).Nisin is an basic compound70
(anode migrating) produced byLactococcus lactisssp.lactisand is stable
under very acidic conditions (Delves-Broughton 1990).Structurally, nisin
consists of 34 amino-acids, including lanthionine and b-methyllanthionine, with
a molecular weight of 3510. Nisin is inhibitory for Gram-positive but not Gram-
negative bacteria, yeast or fungi. The use of nisin as a food preservative was
first suggested by Hirsch at al. (1951) and the incorporation of nisin in canned
food was first permitted in Britain (Anonymous 1959).In 1969, the Joint
FAP/WHO Expert Committee on Food Additives gave approval for its use in food
(Hurst 1966; Hurst and Dring 1968; Hurst 1981; Roller 1991). Currently, nisin is
used as a preservative in cheese spread, processed cheese, and dairy desserts
in some middle-eastern countries.It has been shown that nisin can be used to
killListeria monocytogenesin cottage cheese and yogurt (Benkerroum and
Sandine 1988).
Bacteriocins from various Propionibacterium species have been isolated
and purified.Propionicin PLG-1, produced byPropionibacterium thoenii,has a
wide inhibitory spectrum.It was found to be inhibitory against Gram-positive
and Gram-negative bacteria (Lyon and Glatz 1991;Lyon at el., 1993).
Jenseniin G, a bacteriocin isolated fromPropionibacterium jenseniiP126 has
a narrow inhibitory spectrum, though it inhibits activity closely related classical
propionibacteria, lactobacilli and lactococci (Grinstead and Barefoot 1992).
MicrogardTM (MG) is a product ofPropionibacterium freudenreichiissp.
shermanii fermentation of grade A skim milk (Wesman Foods, Inc. Beaverton,
Oregon).It has been demonstrated to prolong the shelf-life of cottage cheese
against food spoilage psychotrophs (Salih 1990; Weber and Broich 1986). The
proteineous antimicrobial ingredient in MG was shown to be active over a wide
pH range, with optimum activity at pH 5.30 (Al-Zoreky 1991).First patented in
Canada (Ayres et aj.., 1987) and later in the United States (Sandine at al.,71
1992), MG has been approved by the Food and Drug Administration as a
biopreservative and now is present in about 30% of the cottage cheese
produced in the United States (Sandine el al., 1992; Sandine, 1993).Partial
purification of MG has revealed a low molecular weight protein of -700 daltons
(Al-Zoreky 1988).Recent studies also showed that the bacteriocin in MG is
proteineous in nature since it is inactivated by a-chymotrypsin, papain, and
pepsin.However, it is not inactivated by trypsin, suggesting the presence of
anti-trypsin inhibitors inMG. It is antagonistic toward Gram-positive bacteria,
yeasts and some molds (Al-Zoreky 1988).
Despite their great potential, there are several limitations to use of
bacteriocins as biopreservatives in food.Most of the well characterized
bacterocins from lactic acid bacteria do not inhibit Gram-negative bacteria,
which are common causes of food-borne illnesses.Furthermore, the level of
bacteriocins production can be low thus ineffective in most food systems. Under
plasmid control, some of these bacteriocins are also known to be unstable (Kim
1993).
It was the objective of this study to purify the bacteriocin from crude MG
to homogeneity.It was desirable that all organic acids and non-active
macromolecules be removed.Purified bacteriocin was then hydrolysed for
determination of its amino-acid composition and its sequence studied by
Edman degradation and mass spectroscopy.72
MATERIALS AND METHODS
Bacterial Strains and Media
Bacteriocin producer Propionibacterium freudenreichii ssp. shermanii
strain 9616 was used in the fermentation of grade A skim milk, at 30 °C,
neutralized to pH 6.30 and then pasteurized. The product MG was supplied by
Wesman Food, Inc, Beaverton, OR. Pseudomonas putida ATCC 12633 was
grown in lactose broth for 18 hours at 30 °C (0D7000.1). Plate count agar (Difco
Laboratories, Detroit, Mich.) was adjusted with a 10% tartaric acid solution to pH
5.30.100 ml of dissolved Plate Count Agar was aliquoted into each dilution
bottle. All media were autoclaved at 121 °C for 15 minutes.
Bacteriocin Detection and Activity Assay
A modified agar-well diffusion method (Tagg and Mc Given 1971)) was
used to examine the activity of the bacteriocin extracts from MG. Overnight
culture of Pseudomonas putida ATCC 12633 was used as indicator strain for
the routine bacteriocin assays. Plate count agar was tempered to 45 °C before
being inoculated with 0.5 ml of overnight culture of indicator strain.This was
followed by the addition of 2 ml of 2,3,5-triphenyltetrazolium chloride (1% stock)
solution. A 100 ml of this mixture was poured onto each sterile petri-plate (VWR
Scientific Company, Inc., West Chester, PA) and allowed to solidify at room
temperature for 1 hour. The wells (0.75 cm diameter x 1.0 cm depth) in the plate
count agar were aseptically created by a hole-borer. A volume of 100 ul sample
was placed in each well.Bacteriocin titers were determined by a one to one
serological dilution,i.e., one volume of bacteriocin diluted in one volume of73
diluent (1:2).Diluent of 0.1% peptone water was used in the critical dilution
assay.Activity was defined as the reciprocal of the last serial dilution
demonstrating inhibitory activity and presented as activity units (AU) per
milliliter.All culture plates were incubated at 30 °C for 18 hours.
Protein Determinations
Absorbance at 217 nm was used to monitor the protein in fractions from
gel filtration chromatography. Active fractions from ultra-filtration, gel filtration,
anion exchange, and HPLC were assayed for their protein contents by the
method of Lowry at ai.(1951) using bovine serum albumin as the standard
(700 nm). The procedures for this assay are described in the Lowry Total
Protein Assay Kit, No. 5656 (Sigma Chemical Co., St. Louis, MO).
Purification of MicrogardlM
All purification procedures were performed at 4 °C. unless otherwise
stated.
Step 1. pH adjustment and Centrifugation
Crude dairy MG (50 ml) was adjusted to pH 4.00 with anhydrous tartaric
acid (Sigma Chemical Co., St. Louis, MO) and centrifuged at 10,000 x g for 1
hour. The supernatant was decanted and back-neutralized to pH 5.30 with 10%
tartaric acid solution. The supernatant was concentrated to a volume of 24 ml
with a concentrator RC-1009 (Jouan, Inc. Winchester, VA). The conditions for
concentrating the supernatant were set at 150 millitorr vacuum and a74
temperature of -45°C for 1 hour.The supernatant (pH 5.30) was assayed for
activity and total protein concentration.
Step 2.Ultra-Filtration
A total volume of 24 ml of concentrated supernatant was ultra-filtered
using an Amicon filtration cell unit #8050 (Amicon Division, W.R. Grace & Co.
Beverly, MA) An initial molecular weight cut-off membrane was used (YM 10>
10000 MW) at a pressure of 30 psi. A total of 9.2 ml 10,000 MW ultra-filtrate
(10,000-F) was collected. The retaintate (10,000-R) was washed with 0.01 M
sodium acetate buffer (pH 5.3) and 9.2 ml ultra-filtrate (10,000-F) was placed
onto another membrane of 5000 daltons (YM 5 > 5000 MW) to be filtered at a
pressure of 40 psi.All retaintates (5000-R & 1000-R) collected were washed
with 0.01 M sodium acetate buffer (pH 5.3). A volume of 6.2 ml of 5000 MW
ultra-filtrate (5000-F) was filtered through a 1000 daltons cut-off membrane (YM
2 > 1000 MW) at 45 psi.This 1000 ultra-filtrate (5.0 ml) was filtered through a
500 daltons cut-off membrane (YCO5 > 500 MW). A volume of 2.0 ml of 500 MW
ultra-filtrate was collected. All collected samples were assayed for antimicrobial
activity and total protein concentration.
Step 3. Amber lite IRA-400 (OH) Column Chromatography
An Amber lite-OH anion exchanger column (7 x 250 mm) was
equilibrated with 1.0 M NaCO3. After equilibrating with the NaCO3 solution,the
column was washed and re-equilibrated with 0.01 M sodium acetate buffer (pH
5.3) before loading of 1000 MW ultra-filtrate.Eluates from anion-exchanger75
were collected and assayed for activity and protein concentration. GLC was
used to monitor the active fractions for presence of organic acids.
Step 4. Sephedex G-10 Column Chromatography
The active fractions from step 3 were put onto a Sephedex G-10 column
(10 x 400 mm) after equilibration with 0.01 M sodium acetate buffer, pH 5.30.
The eluated active fractions were combined and concentrated by another
Sephedex G-10 chromatography step. A single fraction was assayed for activity
and protein concentration.L-Tyrosine (217.7 MW), Leu-Pro-Pro-Ser-Arg
peptide(568.7 MW), and His-Pro-Phe-His-Leu-Leu-Val-Tyr peptide (1025.2
MW) were used (Sigma Chemical Co., St. Louis, MO) to establisha standard
curve.
Step 5. Reversed-Phase Chromatography
The concentrated active fraction (250 ul) from step 4 was injected intoa
reversed-phase C-18 column (4 x 250 mm, Bio-Sil ODS-5S) equilibrated with
0.1% trifluoroacetic acid (TFA). The collection of HPLC fractions was done at
room temperature with a linear gradient from 0 to 100% acetonitrile in 0.1% TFA
with a flow-rate of 2.0 ml/min.All eluates were evaporated to dryness under
vacuum (150 millitorr) at -45 °C for 1 hour and then rehydrated with cold 0.01 M
sodium acetate buffer (pH 5.30) to a final volume of 500 ul. The eluates from
reversed-phase high performance liquid chromatography were assayed for
activity and total protein concentration.76
Step 6. Amino acid composition and N-terminal amino acid sequence
Active single-peak fraction in sodium acetate buffer ( pH 5.30) from the
reversed-phase high performance liquid chromatography was sent to Central
Services Laboratory, OSU (Corvallis, OR) and AAA Laboratory (Mercer Island,
WA) for amino acid hydrolysis and sequencing. Amino acid sequence was
determined by Edman degradation and mass spectroscopy.RESULTS
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Results of the purification process are summarized in Table 2.1.The
500 MW ultra-filtrate (320 AU/ml) and retentate (160 AU/ml) were less active
when compared to the 1000 MW (640 AU/ml) and 5000 MW ultra-filtrates (640
AU/ml).All retentates except 500 MW's (Figure 2.3 and 2.4) were less active
when compared to the ultra-filtrates (Figure 2.1 and 2.2).The reduction in
activity also corresponded to a lesser protein concentration in the retentates.
Therefore, the 1000 MW ultra-filtrate was extracted for further purification by
anion-exchange chromatography, gel filtration, and reverse-phase high
performance liquid chromatography. The specific activities of fractions from the
anion-exchanger (17.39 AU/mg) and gel filtration increased greatly (108.7
AU/mg).Reversed-phase high performance liquid chromatography, the final
step of purification, produced a single peak of bacteriocin activity (Figure 2.5),
which was recovered in about 4.4-6.0% acetonitrile (Figure 2.6). The overall
purification process resulted in about 25.8-fold recovery and a low yield of
0.065% (Table 2.1).
Molecular weight determination
The molecular weight of purified bacteriocin was estimated to be 859.68
daltons by gel filtration (Figure 2.7).The eluting profile from gel filtration
showed twoactive peaks between absorbance 0.80 and 1.30, respectively
(Figure 2.8).The single and active fraction from gel filtration was also found to
be inhibitory to indicator-organism.78
The m/z data from mass spectroscopy showed two peaks that are in a
series, 295 and 441.7 (Figure 2.9). They suggest charges of 3 (MH+3) and 2
(MH+2), respectively. The molecular weight was determined to be 881.7 (Figure
2.10).
Amino acid composition
Initial amino acid hydrolysis of the single-peak fraction from HPLC
(Central Services Laboratory, Oregon State Univ., Corvallis) revealed the
presence of methionine, valine, glutamate, glycine, serine, and arginine in a
decreasing order of concentration.Analysis from another laboratory (AAA
Laboratory, Mercer Island, Washington) suggested that the peptide consists of 4
residues of methionine, 2 of valine, 1 of glutamic acid, and possibly 1 of glycine.
The molecular weight was calculated to be 926 daltons.79
DISCUSSION
The proteineous nature of the active and acid-free HPLC purified fraction
confirmed that the antimicrobial agent present in MG was a low molecular
weight bacteriocin. The presence of peptide bonds and proteineous nature of
this inhibitory substance was also confirmed by a positive Biruet test with
maximum absorbance at 210 nm (Barefoot and Klaenhammer 1984; Al-Zoreky
1988).In addition, the antimicrobial agent in MG was sensitive to a-
chymotrypsin, pepsin, and papain but not trypsin or catalase (Al-Zoreky 1988).
The trypsin-resistant characteristic was similar to Linecin A, a bacteriocin
produced by Brevibacterium linens ATCC 9175. The low content of basic
amino acids probably explains why Linecin A is resistant to trypsin (Kato at al.,
1991).
The antimicrobial spectrum of MG is similar to Propionicin PLG-1, a
bacteriocin produced by Propionibacterium thoenii; the latter also inhibts some
Gram-negative bacteria, yeasts and molds (Lyon and Glatz 1991; Lyon gl pl.,
1993). On the contrary, Jenseniin G produced by Propionibacterium jensenii
has a narrower spectrum, being active against closely related classical
propionibacteria, some lactococci and lactobacilli but not Gram-negative
bacteria (Grinstead and Barefoot 1992). However, the molecular weight of the
bacterocin in MG is smaller than Propionicin PLG-1 (10,000 daltons) and
Jenseniin G (12,000 daltons).Initial studies by Al-Zoreky (1988) estimated the
molecular weight of the partially purified antimicrobial substance at 700 daltons.
This is consistent with the active fractions from ultra-filtration and gel filtration
chromatography.Compared to other molecular weight cut-off filtrates and
retentates, the fraction occurring between the 1000 MW and 500 MW cut-off
membranes was the most active. This suggested that the molecular weight of80
the antimicrobial agent in MG was less than 1000 daltons but greater than 500
daltons. Gel filtration estimated the size of this antimicrobial substance to be
within the vicinity of 860 daltons. The molecular weight of this bacteriocin is
similar to another antibiotic peptides isolated by Garcia-Bustos gt a (1984).
Active single-peak fraction from reversed-phase HPLC was recovered
between the range 4.4-6.0% acetonitrile solvent with a retention time of 3.29
minutes. The eluting of active agent from the C-18 column at a low solvent
concentration suggested a hydrophillic nature (Shugar and Dean 1990).In this
aspect, MG is different from the hydrophobic Lacticin 481 (Lactococcus lactis
ssp. lactis CNRZ 481) which required a higher concentration of organic solvent
to elute from a reversed-phase HPLC column (Piard alai., 1992).
Overall, the purified bacteriocin in MG showed an increase in specific
activity. Although there was a 25.8-fold recovery of the inhibitory substance, the
yield was quite low (0.0065%), despite concentrating and scale-up injections of
the original sample.It was suggested that a preparatory reversed-phase HPLC
column be used to improve the total yield of the purified product (Ayres 1993).
Preliminary analysis of amino acid hydrolysate revealed the presence of
methionine, valine, glutamate, glycine, serine, and arginine in decreasing order
of concentration. The presence of methionine, valine, glutamic acid and glycine
was confirmed by another laboratory in the state of Washington. Interestingly, a
total of 4 methionine residues was recovered from the amino acid hydrolysate.
Initial amino acid sequencing of the bacteriocin (Central Services Laboratory,
OSU) yielded a methionine residue at the N-terminus. Other than valine from
the second cycle of degradation, no amino acid was detectable upon direct N-
terminal sequencing, indicating the possibility of presence of unusual amino
acids or a cyclic oligopeptide (Mortvedt gt al., 1991). The release of a terminal81
methionine moiety was seen during the Edman degradation of a microcin
(Aguilar at al., 1982).
The antimicrobial activity of the purified bacteriocin from MG is
similar to Microcin A15 (-500 daltons). The release of a methionine moiety
under acidic conditions was also observed in Microcin A15 (Baquero and
Moreno 1984). The antimicrobial mechanism of Microcin A15 was related to L-
methionine in which homoserine-O-transsuccinylase was inhibited.The
inihibition of homoserine-O-transsuccinylase blocks protein synthesis in the
methionine biosynthesis pathway (Aguilar gi al., 1982; Brush and Paulus; 1971;
Lee at ai., 1966). The bacteriocin from MG cannot resemble any fatty acids
found at the amino termini of certain proteins and peptide antibiotics, because
that will require much larger concentrations of methanol or acetonitrile to elute
from the reversed-phase high performance liquid chromatography column
(Alastair ei al.,1982; Kimura at W., 1981; Carr at al., 1982).
Since there were blank cycles with the Edman degradation of purified
MG, the possibility of unusual amino acids should not be ruled out. Nisin (Gross
and Morell, 1971), subtilin (Gross and Kiltz, 1973) epidermin (Allgaier gl
al.,1985), Pep5 (Kellner glad., 1989), and gallidermin (Kellner at w., 1988) have
been shown to contain unusual amino acids such as lanthionine or
methyllanthionines (Stoffels el al., 1992). Some bacteriocins are known to
contain modified amino-acids such as S- (2- aminovinyl)- D- cysteine, lysino-
alanine, dehydroalanine, and dehydrobutyrine, the latter two being the
precursors of lanthionine and 3-methyl-lanthionine (Kellner and Jung 1989).
Incorporation of a lanthionine residue introduces a monosulfur bridge which
results in unique peptide ring structures (Kellner at al.,1988 & 1989).82
The molecular weight determined by gel filtration (859.7 daltons), amino
acid analysis (926 daltons) and mass spectroscopy (881.7 daltons) confirmed
that the bacteriocin in MG was in the vicinity of 700 daltons (Al-Zoreky, 1988).
Various examples on the mode of action of oligopeptides have been
suggested.In one instance, an oligopeptide was thought to be involved in the
depolarization of the membrane of sensitive cells (Aguilar at al., 1982).In
another case, a methionine moiety was shown toinhibit methionine
biosynthesis in treated cells (Duro gi aL,1979).In any case, bacteriocins with
some degrees of hydrophobicity were able to interact with cell membranes by
forming pores, thus disrupting the bacterial transport functions (Muriana and
Klaenhammer 1991).The uncertainty about the structure of the antibiotic
peptide in MG is due to the fact that, to date, the recoverable yields of purified
sample remain low.(a)
(b)
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Figure 2.1Serological dilutions of (a) 10,000 MW filtrate with an activity unit
of 640 AU/ml (b) 5,000 MW filtrate with an activityof 640 AU/ml. Indicator
organism was Pseudomonas putida.(a)
(b)
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Figure 2.2Serological dilutions of (a) 1,000 MW filtrate with an activity unit of
640 AU/ml (b) 500 MW filtrate with an activity of 320 AU/ml. Indicator organism
was Pseudomonas putida.(a)
(b)
C) 1:8
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Figure 2.3Serological dilutions of (a) 10,000 MW retentate with an activity
unit of 40 AU/ml (b) 5,000 MW retentate with an activityof 1 AU/ml. Indicator
organism was Pseudomonas putida.(a)
(b)
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Figure 2.4Serological dilutions of (a) 1,000 MW retentate withan activity unit
of 10 AU/m1 (b) 500 MW retentate withan activityof 160 AU/ml. Indicator
organism was Pseudomonas putida.87
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Figure 2.5Well activity assay of fractions from reversed-phase high
performance liquid chromatography (Bio-Sil ODS-5S, C18 -column); fraction 5
was active against indicator-organism,Pseudomonas putida.88
N
Figure 2.6Isolation of bacteriocin from reversed-phase high performance
liquid chromatography (Bio-Sil ODS-5S, C18 -column); retention time 3.58. The
attenuation level for instrument was 489
1200
1000
Ec
inN
(.1
co
12800 al
C
al
Tn-.-
CD_
a)
600
=00
0
E
400
200
Molecular weight standards
0 Bacteriocin
8 10 12 14 16 18 20
Fractions
Figure 2.7 Molecular weight determination (859.68 daltons) of MicrogardTM
bacteriocin by gel filtration, Sephedex G-101.2000 -
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Figure 2.9Mass spectrometric analysis (ESMS) of MicrogardTM active peaks
from reversed phase HPLC C18 -column ( Bio-Sil ODS-5S)92
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Figure 2.10 Molecular weight determination of active MicrogardTM HPLC
fraction by mass spectroscopy (ESMS)93
Table 2.1 Purification of MicrogardTM
Sample ml (vol) AU/ml Total AU
Total
Protein
mg/m1
Specific
Activity
AU/mg
Activity
recovered
(%)
Fold
Purifica-
tion
Crude
Microgard 24 640 15360 38.01 16.84 100 1.00
10 K (F) 9.2 640 5888 26.91 23.91 38.3 1.42
10 K(R) 14 40 560 3.12 12.82 3.65
,
5 K (F) 6.2 640 3968 23.97 26.70 25.8 1.59
5 K (R) 9.2 1 9.2 0.038 26.04 0.06
a1 K (F) 5.0 640 3200 14.74 43.42 20.83 2.58
1 K (R) 1.0 10 10 16.14 0.620 0.065
500 (F) 2.0 320 640 8.48 37.74 4.167 2.24
500 (R) 1.0 160 160 1.45 110.34 1.042 -
aAnion
Exchange 1.2 40 48 2.30 17.39 0.313 1.03
- Amberiite
aGel
Filtration 1.0 10 10 0.092 108.7 0.065 6.45
-G 10
aHPLC
-reversed
phase
0.250 20 5 0.046 434.78 0.033 25.8
C18
Note: "a" indicates that 1 K-(F) was used for further purification94
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CHAPTER 3
ENHANCEMENT OF MICROGARDTM ACTIVITY AGAINST FOOD SPOILAGE
AND PATHOGENIC MICROORGANISMS
ABSTRACT
The antimicrobial spectrum of MicrogardTM (MG) was extended to
Gram-positive and additional Gram-negative bacteria.Application of MG in
combination with the chelating agents ethylenediaminetetraacetate (EDTA) or
sodium citrate resulted in the inhibition of Listeria monocytogenes ATCC 894,
Salmonella typhimurium ATCC 79631, Escherichia coli 0157:H7, and
Pseudomonas aeruginosa ATCC 10145. The chelating agents were found to
further potentiate the activity of MG against Pseudomonas putida ATCC 12633,
the orginal assay organism.Chelating agents also increased the activity of MG
against contaminating yeasts such as Saccharomyces cerevisiae var
ellipsoideus 1B15 and Candida albicans ATCC 18804. The concentrations
of chelating agents that were required for the enhancement of the activity of MG
varied with different bacteria.However, it was established that 2.0% sodium
citrate and 0.74% EDTA were sufficient in enhancing the inhibitory activity of
MG.Further increase in the concentrations of chelating agents alone were
found to be inhibitory to Ps. putida. In the present study, the inhibition of Gram-
negative bacteria by a combination of MG and citrate was found to be a time-
dependent phenomenon.
Unlike sodium citrate, increasing concentrations of EDTA alone were
found to exert some inhibitory activity against tested bacteria. The time period100
necessary for MG to kill sensitized cells (221 x 102 CFU/ml) was determined to
be 30 minutes.101
INTRODUCTION
A fundamental difference among Gram-positive and Gram-negative
prokaryotes concerns the structure of the cell wall.In Gram-negative bacteria
the wall is distinctively different from Gram-positive bacteria in that the former
have an outer membrane layer consisting of a thin underlying peptidoglycan
layer (Murray gi at., 1965; Glauert and Thorn ley, 1969). The membrane itself
consists of phospholipids, proteins and lipopolysaccharides (Nikaido and
Nakae, 1979).It is the lipopolysaccharide molecules that account for the large
number of negative charges within the outer membrane (White at al., 1972).
These molecules are anchored in the outer membrane, through hydrophobic
interactions with Lipid A (Yamada and Mizushima, 1980).
In Escherichia coli and Salmonella typhimurium, these outer membranes
have been studied extensively in recent years.The strong electrostatic
repulsion between polyanionic molecules and acidic proteins on the outer
portion of the membrane is the major destabilizing force in the membrane
(Schmitges and Henning, 1976).Therefore, stabilization of this membrane
comes from divalent cations, which probably play an important role in
neutralization and bridging between adjacent lipopolysaccharide molecules
(Nikaido and Nakae, 1979; Lugtenberg, B., and L. van Alphen, 1983; Nikaido
and Vaara, 1987).
Magnesium (Mg2+) and calcium (Ca2+) ions have been shown to stabilize
disrupted outer membranes of E. coli (Nikaido and Nakae, 1979) and
Pseudomonas aeruginosa (Gray and Wilkinson, 1965). The combination of
negative charges and divalent cation cross-bridging of lipopolysaccharide
molecules provide Gram-negative bacteria with resistance to lysozyme,
hydrophobic antibiotics (Smit and Nikaido, 1978; Hancock 1984; Nikaido and102
Vara, 1987), bile salts, lipases, proteases, and detergents (Nikaido and Nakae,
1979; Lugtenberg, B., and L. van Alphen, 1983). The addition of Ca2+ and Mg2+
helps to restore the resistance of cells injured by lysozyme (Ray, 1993). The
strong association between divalent cations and the outer membrane also
excludes large hydrophillic and most hydrophobic and amphiphillic molecules
(Nikaido and Nakae, 1979; Hancock, 1984; Nikaido and Vara, 1987).It has
been hypothesized by Nikaido and Nakae (1979) that when hydrophillic
molecules pass through the outer membrane, they do so bymeans of water-
filled pores and carrier-mediated transport.
The removal of divalent cations by EDTA from the outer membranes of E.
coil and Ps. aeruginosa results in the release of lipopolysaccharide (Leive,
1965; Rogers gt gI., 1969; Roberts el at., 1970). By chelating Mg2+ from the
outer membrane sites, there is an enhancement of killing by polycationic
antibiotics (Sykes and Morris, 1975) as well as the uptake of lysozyme and b-
lactams. The presence of divalent cations indicates that the lipopolysaccharide
has a single class of divalent cation-binding sites that are responsible for the
permeability alterations of the outer membrane (Coughlin gi ,1981; Schinder
and Osborn, 1979).It has been estimated that EDTA causes the loss of 30%
and 67% of the total lipopolysaccharide in E. coli at 37 °C or 4 °C, respectively
(Leive gl1968; Graham a gl., 1979). The alteration of lipopolysaccharide
molecules in Gram-negative bacteria also enables bacteriocins tocome in
contact with the cytoplasmic membrane (Ray, 1993).However, even in the
absence of lipopolysaccharide synthesis, injured cells can regain barrier
function by reorganizing exisiting molecules in the outer membrane (Ray,
1993).
It has been observed that whenPseudomonas fluorescenswas grown
on succinate, the bacteria became sensitive to the permeabilizing effects of103
EDTA (Walker and Durham, 1975).Also, the incorporation of phosphate has
been shown to cause the outer membrane of P.fluorescens to bind to
polymyxin B (Dorrer and Teuber, 1977).
In Gram-positive bacteria, the sulfhydryl groups of Bacillus cereus
spores are critical for proper membrane function. These groups are potential
sites to which antibiotics and bacteriostatic agents are attracted.Inhibition of
outgrowing B. cereus spores is a consequence of interfering with specific
sulfhydryl groups since they exist in a sterically unhindered environment,
offering accessibility to antibiotic agents (Morris at at, 1984). Dehydroalanine
residues in nisin are thought to interact with these membrane sulfhydryl groups,
resulting in the loss of cell viability (Gross and Morrell, 1967, 1971; Liu and
Hansen, 1990).Inactivation of cells also could be due to disruption of the
proton motive force or loss of membrane integrity (Kordel at al., 1986; Liu and
Hansen, 1990). Use of EDTA as chelating agent to alter Gram-positive bacterial
cell walls has not been reported.
Nisin, once thought to be inhibitory for only Gram-positive bacteria,has
been demonstrated to inhibit Salmonella spp. and other Gram-negative
organisms when used with the chelating agent EDTA (Blackman It al., 1989;
Stevens at al., 1991). Cells treated with either EDTA or nisin were not inhibited
(Stevens 2/ at., 1991). The inhibition of Salmonella spp. by a nisin-EDTA
combination is a time dependent phenomenon (Stevens at at., 1991).It was
also demonstrated that cellular contents were released (Hancock 1984; Nikaido
and Vaara, 1987) when Salmonella spp. were treated with the combination of
nisin and EDTA (Stevens el al.,1992a ).Combination of nisin with ethylenebis
(oxyethylene-nitrilo) tetraacetic acid, citric acid monohydrate, and sodium
phosphate dibasic was examined by Stevens at al. (1992b) for effect on Gram-
negative bacterial cells.It was found that the inhibitory effect from the use of104
citrate was comparable to the EDTA treatment. Polyphosphates could be used
effectively but only at a low pH (Stevens ed a., 1992b).
In this study, sodium citrate and EDTA were used to potentiate the activity
of MG against selected Gram-positive bacteria, Gram-negative bacteria and
yeasts.Various combinations of sodium citrate and MG were used to
demonstrate the enhancement against common food spoilage organisms in
cottage cheese. The effects of treatment conditions for various organisms were
evaluated. Both EDTA and sodium citrate were used to sensitize bacteria and
yeasts before the application of MG.In addition, the period of exposure to
citrate-MG was compared to the rate of cell death.105
MATERIALS AND METHODS
Preparation of MicrogardTm
Liquid dairy MG (pH 6.38) and non-dairy MG (pH 6.32) were obtained
from Wesman Foods, Inc., Beaverton, OR. Initially all MG was adjusted to pH
4.00 with sterile anhydrous tartaric acid (Sigma Chemical Co., St. Louis, MO) to
precipitate casein, other milk proteins and dead bacterial cells.The acidified
sample was centrifuged at 10,000 rpm for 30 minutes.Supernatnant was
decanted into another container and back-neutralized with 1.0 N NaOH to pH
5.30. The final supernatant was filter-sterilized using a 0.45 gm pore diameter
filter (Nalge Co., Rochester, NY).All pH adjustments were measured with a
Corning 125 pH meter at room temperature.
Preparation of growth media for bacteria
Plate count agar (PCA) was prepared and aliquoted (100 ml) into dilution
bottles. The pH of medium was adjusted with 10% tartaric acid solution to pH
5.30.Lactose broth, pH 7.00 (Difco Laboratories, Detroit, MI) was used to
cultivate Pseudomonas strains and Escherichia coli.
Brain and heart infusion agar, pH 5.30 (Difco Laboratories, Detroit, MI),
was prepared and aliquoted (100 ml) into dilution bottles.Brain heart infusion
broth was used to grow Listeria monocytogenes ATCC 894 and Salmonella
typhimurium ATCC 79631at 30 °C.All media were autoclaved at 121°C for
15 minutes.106
Preparation of growth media for yeasts
Potato dextrose agar (Difco Laboratories, Detroit, MI) was autoclaved at
121 °C for 15 minutes before adjustment to pH 3.50 with 10% sterile tartaric
acid solution (Schwab, 1984). Mycophil broth (Difco Laboratories, Detroit, MI)
was used to cultivate Saccharomyces cerevisiae var ellipsoideus 1B15 and
Candida albicans ATCC 18804 at 30 °C.
Preparation of buffers and chelating agents
Citrate buffer (0.1 M), pH 5.30, was prepared by titrating 0.1 M citric acid
with 0.1 M sodium citrate. HEPES (Sigma Chemical Co., St. Louis, MO) buffer
was titrated to pH 5.30 with 0.1 N HCI solution. Sodium acetate (0.01 M) buffer,
pH 5.30 was prepared by titrating with 0.1 M acetic acid.
The composition of cell buffer (CB) was 50 mM Tris-HCI (pH 5.30), 1mM
MgSO4,4mM CaCl2, and 0.1% gelatin (Sigma Chemical Co., St. Louis, MO &
Difco Laboratories, Detroit, MI).Final pH of 5.30 was achieved with 1N HCI or
1N NaOH. Stock solutions of 0.1%, 0.5%, 1.0%, 1.5%, and 2.0% sodium citrate
were prepared in CB.All sodium citrate solutions were titrated to pH 5.30.
Stock solutions of 0.037% (1 mM), 0.1861% (5 mM), 0.37% (10 mM), 0.56% (15
mM), and 0.74% (20 mM) ethylenediaminetetraacetate (EDTA) were prepared
in CB, pH 5.30. Peptone water (0.1%) was used as diluent (Difco Laboratories,
Detroit, MI).All buffers and diluents were filter-sterilized by 0.45 gm pore
diameter filters (Nalge Co., Rochester, NY).107
The effect of MicrogardIM in various buffers
Dairy MG was diluted with different amounts of 0.1M citrate buffer (pH
5.30), HEPES buffer (pH 5.30) and distilled water.A seriological dilution
scheme was adopted. Each dilution was assayed for activity at pH 5.30. The
disk-activity assay involved adding of 0.5 ml Pseudomonas putida ATCC
12633 to 100-m1 of PCA (Difco Laboratories, Detroit, MI). The staining reagent,
1% 2,3,5-triphenyltetrazolium chloride (2 ml), was added to the molten agar. A
total of 18 ml was aliquoted into 100 x 15 mm sterile petri dishes (VWR
Scientific Inc., West Chester, PA). Upon solidification, 1/2-inch diameter (13
mm) sterilized filter paper disks (Schleicher & Schuell Inc., Keene, NH) were
aseptically placed on each agar. A volume of 100 RI sample was placed on the
surface of the paper disks. Plates were incubated at 300 C, agar-side down, for
18 hours.
Enhancing effect of sodium citrate on the inhibitory activity of diluted
MicrogardThi
All procedures pertaining to disk-activity assay in this experiment remain
the same as have been described above, except for the further addition of
different sodium citrate concentrations (0.05%, 0.1%, and 0.2%) into 100-m1
PCA (Difco Laboratories, Detroit, MI).Non-dairy MG was serologically diluted
and assayed for activity.The final pH of PCA was adjusted to 5.30 before
assaying against Pseudomonas putida ATCC 12633.Plates were incubated
at 300 C, agar-side down, for 18 hours.108
Effect of chelating agents with MicrogardIM and incubation time on bacterial
growth
Overnight culture (0D600 0.1) of Pseudomonas putida ATCC 12633
was centrifuged at 13,000 X g for 5 minutes. The havested cells were washed
twice with CB, pH 5.30, before resuspending (1 ml) in various concentrations of
sodium citrate or EDTA solutions.All sodium citrate/EDTA treated cells were
incubated at 30 °C for 30 minutes.After incubation, the treated cells were
washed twice with CB, pH 5.30. Subsequently, cell pellets were suspended in
non-dairy MG at 30 °C for 15, 30, 60, 90, 120, or 150 minutes.After each
incubation period, each batch of samples was washed and resuspended in CB
before plating for viable cell counts. All culture plates were incubated at 30 °C
for 18 hours.
Effect of chelating agents combined with acetic and propionic acids against
Gram-negative bacteria
Acid-mixtures consisting of 12,206.7 ppm (12.21 µg /ml) acetic acid and
5393.16 ppm (5.4p.g /ml) propionic acid were used to simulate the
concentrations of these acids in crude MG. Various concentrations of citrate
and EDTA, in CB (pH 5.30), were used to sensitize the Gram-negative
organisms for a period of 30 minutes.After 30 minutes of incubation, and
washing in CB, pH 5.30, the acid-mixtures were used instead of MG to interact
with the bacteria for another 30 minutes. After the incubation period, the cells
were retrieved for viable cell counts.Two acid-mixtures were used in this
experiment; the original preparation and a 1:2 diluted acid-mixture.109
Effect of chelating agents on the activity of Microgarcia-A against Gram-negative
& Gram-positive bacteria and yeasts
Overnight cultures (0D600 0.1) of Pseudomonas putida ATCC 12633,
Pseudomonas aeruginosa ATCC 10145, Escherichia coli0157:H7,
Salmonella typhimurium ATCC 79631, Listeria monocytogenes ATCC 894,
Saccharomyces cerevisiae var ellipsoideus 1B15, and Candida albicans
ATCC 18804 were harvested by centrifuging at 13,000 X g for 5 minutes. The
cells were washed twice with CB, pH 5.30, and then resuspended (1 ml) in
various concentrations of sodium citrate or EDTA solutions. The suspensions
were incubated in a 30 °C water bath for 30 minutes.After incubation, cells
were centrifuged at 13,000 X g for 5 minutes, and then washed twice with CB,
pH 5.30. The cell-pellets were resuspended in undiluted MG (1 ml) and then re-
incubated at 30 °C for another 30 minutes. After the incubation period, all cells
were centrifuged and washed twice with CB, pH 5.30. The cell-pellets were
resuspended in a final 1 ml-volume of CB before plating for viable cell counts.
The controls included untreated cells, cells treated with sodium citrate or EDTA
alone, and MG-treated cells alone.All culture, except E.coli (37°C) were
incubated at 30 °C for 18 hours.
The effect of sodium citrate on Microgard-TA activity against Gram-negative
bacteria and yeasts in cottage cheese
Cottage cheese and half and half cream (12% milk fat) were obtained
from Albertson's Food Center. A 100-m1 volume of half and half cream was
aliquoted into steriled 250-m1 Eryermeyer flasks. A total of 0.25 grams of spray-
dried dairy MG was added to each flask and mixed evenly.Various110
concentrations of sodium citrate (0.1%, 0.5%, 1.0%, 1.5%, and 2.0%) were
incorporated into the half and half cream. The pH of this mixture was adjusted
to 5.30 before incorporating into cottage cheese. A total of 1ml overnight
Pseudomonas putida(107 CFU/ml) culture was inoculated before any addition
of cottage cheese (150 grams) into each flask.Negative controls were set up
for various concentrations of sodium citrate and MG. Positive controls involved
the inoculation of bacteria without the addition of sodium citrate or MG. All
experimental samples were incubated at 8°C (Bodyfelt and Davidson, 1975) for
2,3,4,7,10,15, or 21 days.
For viable cell counts, 11 grams of cottage cheese were added to a
stomacher with 99 ml 0.1% peptone water diluent.All samples were diluted
appropriately and 0.1 ml of the suspension was plated for bacterial cell counts.
The pH for all inoculated samples were measured by a Corning 125 pH-meter
at room temperature.The pH for all samples was adjusted to 5.30 when
necessary.
Effect of sodium citrate on the activity of MicrogardIM against Gram-negative
bacteria and yeasts in half and half cream
Volumes of 100 ml half and half cream (12% milk fat) were aliquoted into
sterile 250-m1 Eryermeyer flasks.Net weight of 0.25 grams spray-dried dairy
MG was mixed evenly into the cream. Concentrations of 0.1%, 0.5%, 1.0%,
1.5%, and 2.0% of sodium citrate were incorporated into the half and half
cream. The pH of this mixture was adjusted to 5.30.Overnight cultures of
Pseudomonas putida,Saccharomyces cerevisiae var ellipsoideus 1B15, or
Candida albicans ATCC 18804 were diluted to approxmately 100 cells per ml
before inoculating the half and half cream. Negative controls were set up for111
various concentrations of sodium citrate and MG. Positive controls involved the
inoculation of bacteria or yeasts without the addition of sodium citrate or MG.
The samples containing Ps. putida, S. cerevisiae, and C. albicanswere
incubated at 8 °C (Bodyfelt and Davidson, 1975) for 28, 26, and 33 days
respectively.
All samples were diluted appropriately and 0.1 ml aliquots plated for
bacterial cell counts. The pH for all inoculated samples was measured using a
Corning 125 pH-meter at room temperature.The pH for all samples was
adjusted to 5.30 when necessary.112
RESULTS
Effect of MicrogardIU activity in distilled water. HEPES and citrate buffers on
bacterial cells
Serological dilutions of MG in citrate buffer (pH 5.30) produced an
enhancement in activity (Table 3.1). There were two active fractions resulting
from citrate-diluted MG (1:128 and 1:8192 dilutions). An activity unit (AU) is
defined as recipocal of the highest dilution yielding a definite inhibition zone on
the indicator-bacterial lawn. Therefore, the active fractions were calculated to
be 1280 activity units per ml (AU/ml) and 81920 AU/ml, respectively.However,
dilution with distilled water and HEPES buffer, pH 5.30,produced no active
fraction after 1:64 dilution. The activity units for MG in water and HEPES buffer
were calculated to be only 640 AU/ml.
Enhancing effect of sodium citrate on the inhibitory activity of diluted
MicrogardlM
Compared to MG controls, an increase in citrate concentrations was
shown to enhance the inhibitory activity of MG (Figure 3.1 and Figure 3.2).
Furthermore, with 0.1% citrate, the activity of diluted MG (1:64) was shown to be
enhanced (Figure 3.3).The citrate controls were not inhibitory to the assay
organism.113
Effects of chelating agents with MicrogardIM and incubation time on bacterial
arowth
Results indicated that increases in citrate concentration potentiated the
activity of MG (Figure 3.4 - Figure 3.8).It was also observed that after an
incubation period of 60 minutes, the bacteria were completely inhibited by MG,
with or without the presence of citrate.In addition, the 1.0% citrate-MG
combination, after 30 minutes of incubation, produced the optimum inhibitory
effect on Pseudomonas putida.However, an increase in citrate concentration
beyond 1.0% did not further enhance the activity of MG. Controls showed that
the increase in the citrate concentrations alone did not inhibit Ps. putida.
After 15 minutes of incubation, the activity of MG was shown to be
enhanced by the increase in the concentrations of EDTA (Figure 3.93.13).
However, with 0.037% and 0.1861% EDTA, MG was enhanced only after 15
minutes but not 30 minutes of incubation (Figure 3.9 & Figure 3.10).Results
also indicated that with 0.56% or higher concentrations, the combination of
EDTA-MG completely inihibited the bacteria after 30 minutes of incubation
(Figure 3.12 & Figure 3.13).However, the EDTA controls showed that
progressive increments in EDTA concentration also resulted in inhibitions of Ps.
putida.
Effect of chelating agents on acetic and propionic acids against Gram-negative
bacteria
The increase in concentrations of sodium citrate did not cause the activity
of acid-mixture (undiluted) to be more active against Pseudomonas putida
(Figure 3.14).On the contrary, as the percent concentrations of citrate114
increased, the acid-mixture was rendered less effective in inhibition of the
Gram-negative organism. The effect of EDTA on acetic and propionic acids
resulted in an approximately 2 -login reduction of Ps. putida (Figure 3.15).
The sodium citrate in diluted acid-mixture (1:2) causedmore than a 2-
logi 0 reduction in bacterial cell counts (Figure 3.16).EDTA was shown to
enhance the activity of diluted acid-mixture but less effectively than the
undiluted mixture (Figure 3.17).
Enhancement by chelating agents of MicrogardIA activity against Gram-
negative bacteria
The effect of MG on Pseudomonas putida ATCC 12633was further
enhanced by the incorporation of sodium citrate (Figure 3.18).Citrate
concentration of 0.5% was found to be adequate for the enhancement against
Gram-negative bacteria.However, it took 0.370% EDTA to cause a similar
effect against this bacterium (Figure 3.19).It was also noted that the citrate
controls were different from EDTA controls, in that the latter was inhibitory at
higher concentrations.
Sodium citrate, at a concentration of 0.5% or greater, was found to
enhance the activity of MG against Escherichia coli 0157:H7(Figure 3.20).
On the contrary, increased in concentrations of EDTA did not potentiate the
activity of MG against this organism. Results also pointed out that the EDTA-MG
combination was not effective against Gram-negative bacteria (Figure 3.21).
Although MG was effective (2 -logio reduction) against Salmonella
typhimurium ATCC 79631, the addition of sodium citrate did not produce further
enhancement in its activity (Figure 3.22). Similarly, the application of EDTA and
MG combination did not enhance inhibition of S. typhimurium (Figure 3.23). On115
the contrary, in both cases, the incorporation of chelating agents had an
antagonizing effect on the activity of MG.
Originally, MG was not effective against Pseudomonas aeruginosa
ATCC 10145 (Figure 3.24).However, with the incorporation of 0.1% sodium
citrate, a 2-logio reduction in bacterial cell counts was observed.In addition,
the rate of cell death also increased with the increase in concentrations of the
chelating agent in MG.Interestingly, citrate controls showed no sign of
inhibitory activity against Ps. aeruginosa.With EDTA as the chelating agent,
MG was shown to be highly active against Gram-negative organisms.A
concentration of 0.03722% EDTA was sufficient to cause a 4-log10 reduction in
bacterial cells (Figure 3.25).
Effect of chelating agents on the activity of MicrogardIM against Gram-positive
bacteria
MG was found to be inhibitory against Listeria monocytogenes ATCC
894.After a 30-minutes exposure to MG, there was a 2 -login reduction in
bacteria cell counts (Figure 3.26). Incorporation of 1.5% sodium citrate resulted
in slight enhancement of MG against this bacterium. However, further increases
in concentrations of citrate did not promote further enhancement of MG.
The use of EDTA was also successful in potentiation of the activity of MG
and increases in concentration enhanced the effect (Figure 3.27).It was found
that 0.5583% EDTA was the optimum.116
Effect of chelating agents on the activity of MicrogardIM. against yeasts
Saccharomyces cerevisiae var ellipsoideus 1B15 was found to be
sensitive to MG.Results showed a 1-log10 reduction in viable cell counts
(Figure 3.28). The use of 0.1% sodium citrate with MG was optimum for the
inhibition of S.cerevisiae.Similarly, 0.1861% EDTA was found to enhance
the activity of MG against the yeast cells (Figure 3.29). However, there was no
further change in the activity of MG when treated with higher concentrations (>
0.1861%) of EDTA.
Candida albicans ATCC 18804 was found to be sensitive to MG. An
increase in concentrations of sodium citrate, from 1.0% to 2.0% resulted in an
enhancement of MG activity against the yeast cells (Figure 3.30). The use of
EDTA as chelating agent, however, did not potentiate the activity of MG against
this organism (Figure 3.31). However, controls showed that the yeast cells were
inhibited by increasing EDTA concentrations.
The effect of sodium citrate on MicrogardIM activity against Gram-negative
bacteria and yeasts in cottage cheese
Due to the high inoculation rate of Pseudomonas putida ATCC 12633
(107 bacteria/ml), the effect of citrate on MG activity was less pronounced.
During the first 5 days, the citrate-MG combination was able to somewhat
enhance inhibition on Ps. putida.A 2.0% citrate-MG combination was
consistent in the inhibition of the bacteria (Figure 3.32).Further incubation
produce erratic results. The efficiency of MG-citrate did not affect growth of the
bacteria after 10 days (data and graphs not presented). However, 2.0% citrate
in MG, after the tenth day, was useful in inhibition of yeasts.It was also117
observed that the lower citrate concentrations in MG did not inhibit the growth of
yeasts in cottage cheese (Figure 3.33).
Effect of sodium citrate on the activity of MicrogardIM against Pseudomonas
putida in half and half cream
The growth of Pseudomonas putida ATCC 12633in the half and half
cream was inhibited by MG alone for a period of 7 days (Figure 3.34). Citrate
concentrations of 0.5% and more were found to enhance its activity against the
Gram-negative bacterium.Furthermore, a 1.0% citrate-MG combination was
active against Ps. putida for 30 days (100% inhibition).
Effect of sodium citrate on the activity of Microgard11-11 against yeasts in half and
half cream
It was shown that the 0.5% citrate-MG combination was effective for
inhibition of Candida albicans ATCC 18804 for up to 33 days (Figure 3.35). At
2% citrate concentration, MG was found to exert a lesser inhibitory effect on the
yeast. Saccharomyces cerevisiae var ellipsoideus 1B15 was less sensitive to
MG than C. albicans (Figure 3.36).However, after 20 days of incubation, a
concentration of 1.0% citrate-MG was found to be optimum for inhibition of S.
cerevisiae. Similar to C. albicans, higher citrate concentrations did not enhance
the activity of MG.118
DISCUSSION
When crude MG was diluted with citrate buffer (pH 5.30), two enhanced
activities were observed, one at 1:128, and the other at 1:8192 dilution; in
between, citrate was without effect.It was evident that the active ingredient(s) in
MG was potentiated by citrate. The inhibitory activity from the lower dilutions
could be attributed to the presence of organic acids.However, the higher
dilutions produced a more active fraction inferring that it could be due to a
bacteriocin.It seemed that a trace amount of the bacteriocin in citrate buffer
was sufficient to cause inhibition of Pseudomonas putida. However, in distilled
water and HEPES buffer (pH 5.30), the antimicrobial substance in MG was
considerably less active.In both diluents, only one type of activity was
detectable. This indicated that trace amounts of MG antimicrobial substance(s)
in water or HEPES buffer was not potentiated against the assay organisms
under these conditions.Also, the citrate-enhancing phenomenon could serve
as a rapid and sensitive method of detecting bacteriocin in a chelator-sensitized
environment.
The inhibitory effect on Gram-negative bacteria by the citrate or EDTA-
MG combinations was a time-dependent phenomenon (Stevens gi 81.,1991).
The inhibitory effect against Ps. putida, also increased with the incubation
period.In addition, different concentrations of chelating agents exerted varying
effects on the activity of MG. In general, the optimum effect was achieved when
further increases in chelator concentrations did not enhance activity.Data
herein reported also showed that organisms responded differently to various
chelating agents. This could be due to the fact that the outer membranes of
different Gram-negative bacteria are stabilized by different amounts or types of
divalent ions in the lipopolysaccharide layer (Nikaido and Nakae, 1979). The119
structures of EDTA and citric acid make them good chelating agents because of
the surface charges they carry (Windholz at al.,1983). EDTA was more effective
because it strongly binds a variety of divalents cations, including calcium and
magnesium (Nikaido and Vaara, 1985). The removal of magnesium ions by
chelators disrupts the cell walllipopolysaccharide, resulting in damage to the
permeability of the bacterial membrane (Nikaido and Vaara, 1987).Nisin is
believed to permeate disrupted cell outer membranes, inactivating bacteria at
the cytoplasmic membrane (Morris It al., 1984; Stevens at al.,1991).In the
present study, it was found that the permeability of acidic metabolites through
the cell membrane was facilitated by EDTA or citrate.Findings showed that
mixture of acetic and propionic acids has a greater inhibitory effect when used
with sodium citrate. Under the same conditions, it was observed that the acidic
mixture was more potent when diluted by water. EDTA was more effective in
concentrated organic acid mixture than a diluted one.It is obvious that EDTA
works efficiently in an acidic environment.
The effective incubation temperature for cells treated with either citrate-
MG or EDTA-MG appeared to be between 30 and 37 °C. This is similar to the
effective temperature range of between 30 and 42 °C for nisin-EDTA
combinations against Salmonella spp. (Stevens It al., 1992b). The effect of
exposure temperature may be important for citrate or EDTA interactions with MG
in food systems.
In cottage cheese and cream, the effect of chelating agents on MG was
less pronounced. The MG activity was probably affected by the protein and lipid
content within the cheese and milk media.In this regard, the presence of fat in
food has been found to cause a decrease in the activity of nisin (Daeschel,
1990).However, citrate-MG interaction in CB (pH 5.30) was effective in the
inhibition of Pseudomonas putida ATCC 12633 and Escherichia coli 0157:H7120
but not Pseudomonas aeruginosa ATCC 10145 or Salmonella typhimurium
ATCC 79631 (Table 3.2 and Table 3.3).Unlike the effect of nisin-EDTA
(Blackburn et al., 1989; Roller, 1991; Stevens at al., 1991,1992a,1992b) the
EDTA-MG combination was not effective against E. coli or S. typhimurium. The
differences in the inhibitory effects for both bacteriocins could infer that there is
variability among different lipopolysaccharide layers of Gram-negative bacteria
(Hancock, 1984; Nikaido and Nakae, 1979).
Unlike previous works on MG (Al-Zoreky, 1988), the bacteriocin was
found to be inhibitory against E. coli and S. typhimurium.Also in the present
study, MG was found to be inhibitory against L. monocytogenes, aGram-
positive bacterium.Moreover, sodium citrate and EDTA were shown to be
effective in the enhancement of MG against this organism. Recently, nisin also
has been shown to exert a bactericidal effect on L. monocytogenes (Mohamed
ei al.,1984; Benkerroum and Sandine, 1988; Asperger el W.,1989; Carminati et
al., 1989; Harris a al., 1989; Maisnier-Patin at a1.,1992).Citrate-MG has
potential for use in food safety applications since L. monocytogenes is common
in food and has been isolated from silage, milk, cheese, vegetables and meat
(EI-Gazzar and Marth, 1991; Skovgaard, 1990).
The peptidoglycan matrix of Gram-positive bacteria consists of a variety
of polysaccharides and polyphosphates known as teichoic acids (Stanier .t
W.,1986). These teichoic acids constitute the major antigens of these bacteria
and are found on the outer surface of the peptidoglycan. The acids are charged
and could affect the passage of ions through the outer surface layers.The
competitve binding of Cl- and phosphate anions to the lipoteichoic acid of
sensitized cells has been shown to cause a decrease in the activity of pediocin
AcH (Bhunia a DI, 1991; Kim, 1993).Although the mode of action of MG
remains unknown, studies of nisin and other bacteriocins could help to shed121
some light on its inhibitory nature against Gram-positive bacteria.Beside
disruption of the outer membrane by chelating agents, several possible
mechanisms of membrane destabilization by MG have been hypothesized. The
loss of viability of Gram-positive organisms could be attributed to (1) disruption
of membrane potential, (2) the damaging influx of MG into the cells, (3) the
presence of specific receptors on which bacteriocin moleculescould be
adsorbed or bound, and (4) loss of a specific membrane constituent(s) as a
result of cell lysis.
Bacterial cell membrane potential was shown to be dramatically
decreased when amino acids, ions and ATP were released from nisin-treated
cells and cytoplasmic vesicles (Ruhr and Sahl, 1985; Kordel and Sahl, 1986;
Kordel gt al.,1989; Barefoot and Nettles, 1993; Garceraal.,1993; Bruno Mal.,
1993).The disruption of outer membrane by physical means will cause a
structural discontinuity, resulting in permeability of bacteriocins across the outer
membrane. The presence of specific antibiotic-binding receptors, such as
sulfhydryl groups, has been shown by Morris gi al. (1984). These sulfhydryl
groups exist in a highly intereactive environment and therefore are easily
inhibited by sulfhydryl agents or possibly bacteriocins.In addition, the
sulfhydryl groups appeared to be in communication with one or more histidines,
and covalent modification of either sulfhydryl group or histidine has a profound
recipocal effect on the reactivity of the other ( Morris at gl., 1984). Similar to
nisin, it is possible that MG may have a specific capability to alter, either directly
or indirectly, the membrane sulfiydryl groups causing bacteriostasis in bacteria.
Itis also possible that interferences by chelating agents on these specific
receptors enhance the effect of bacteriocins. The affinity of nisin and Pep 5 is
strongly dependent on the presence of negatively charged phospholipids and
electrostatic interactions (KordelW.,1989). Therefore, the removal of divalent122
cations by chelating agents could produce effective binding of bacteriocins to
the cell membrane. The end product of bacteriocins could be seen in the
collapse of the proton motive force in L. monocytogenes and Clostridium
sporogenes PA 3679 after treating with pediocin JD (Christensen and Hutkins,
1992) or nisin (Okereke and Montville, 1992).
The inhibitory effect of citrate-MG or MG alone has been extended to
yeast cells. The use of EDTA remains uneffective against S. cerevisiae or C.
albicans(Table 3.2 and Table 3.3). Presently, the inhibitory mechanism of MG
against yeasts and molds is still unclear. However, it is obvious that MG and
citrate-MG combinations do inhibit yeasts as well as a wide spectrum of
bacteria, and therefore has potential application in food systems.Non-Inhibitory
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Figure 3.1Enhancement of sodium citrate in non-dairy MicrogardTM (MG)
against Pseudomonas putida ATCC 12633.(a) sodium citrate controls, (b)
non-dairy MG controls, and (c) effect of citrate in undiluted MG124
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Figure 3.2Enhancement of sodium citrate in non-dairy MicrogardTM (MG)
against Pseudomonas putida ATCC 12633. (a) effect of citrate in diluted (1:2)
MG (b) effect of citrate in diluted (1:4) MG125
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Figure 3.3Enhancement by sodium citrateofactivityofnon-dairy
MicrogardTM (MG) against Pseudomonas putida ATCC 12633.(a) effect of
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Figure 3.4 Effect of 0.1% citrate in Microgard on growth of Pseudomonas
putida ATCC 12633 with respect to time109
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Figure 3.5 Effect of 0.5% citrate in Microgard on growth of Pseudomonas
putida ATCC 12633 with respect to time15 30 60 90
time (min)
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Figure 3.6 Effect of 1.0% citrate in Microgard on growth of Pseudomonas
putida ATCC 12633 with respect to time109
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Figure 3.7 Effect of 1.5% citrate in Microgard on the growth of Pseudomonas
putida ATCC 12633 with respect to time109
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Figure 3.8 Effect of 2.0% citrate in Microgard on growth of Pseudomonas
putida ATCC 12633 with respect to time109
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Figure 3.9 Effect of 0.037% EDTA in Microgard on the growth of Pseudomonas
putida ATCC 12633 with respect to timeE
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Figure 3.10 Effect of 0.1861% EDTA in Microgard on the growth of Pseudomonas
putida ATCC 12633 with respect to timeE
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Figure 3.11Effect of 0.37% EDTA in Microgard on the growth of Pseudomonas
putida ATCC 12633 with respect to time15 30 60 90
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Figure 3.12 Effect of 0.56% EDTA in Microgard on growth of Pseudomonas
putida ATCC 12633 with respect to time109
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Figure 3.13 Effect of 0.74% EDTA in Microgard on growth of Pseudomonas
putida ATCC 12633 with respect to timeE
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Figure 3.14 Effect of sodium citrate in concentrated acetic and propionic acids
on inhibition of Pseudomonas putida ATCC 12633137
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Figure 3.15 Effect of EDTA in concentrated acetic and propionic acids
on inhibition of Pseudomonas putida ATCC 12633138
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Figure 3.16 Effect of sodium citrate in diluted acetic and propionic acids
on inhibition of Pseudomonas putida ATCC 12633139
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Figure 3.17 Effect of EDTA in diluted acetic and propionic acids on inhibition
of Pseudomonas putida ATCC 12633U
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Figure 3.19 Effect of EDTA on inhibitory activity of non-dairy Microgard against
Pseudomonas putida ATCC 126330 0.1 0.5 1 1.5
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Figure 3.20 Effect of sodium citrate on inhibitory activity of non-dairy Microgard
against Escherichia coli 0157:H7143
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Figure 3.21Effect of EDTA on inhibitory activity of non-dairy Microgard
against Escherichia coli 0157:H70 0.1 0.5 1 1.5
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Figure 3.22 Effect of sodium citrate on inhibitory activity of non-dairy Microgard
against Salmonella typhimurium ATCC 79631145
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Figure 3.23 Effect of EDTA on inhibitory activity of non-dairy Microgard
against Salmonella typhimurium ATCC 796310 0.1 0.5 1 1.5
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Figure 3.24 Effect of sodium citrate on inhibitory activity of non-dairy Microgard
against Pseudomonas aeruginosa ATCC 1014500.03722 0.1861 0.3722 0.5583 0.7444
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Figure 3.25 Effect of EDTA on inhibitory activity of non-dairy Microgard against
Pseudomonas aeruginosa ATCC 10145148
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Figure 3.26 Effect of sodium citrate on inhibitory activity of non-dairy Microgard
against Listeria monocytogenes ATCC 8940 0.18610.37220.55830.7444
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Figure 3.27 Effect of EDTA on inhibitory activity of non-dairy Microgard against
Listeria monocytogenes ATCC 894E
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Figure 3.28 Effect of sodium citrate on inhibitory activity of non-dairy Microgard
against Saccharomyces cerevisiae var ellipsoideus 1B1500.03722 0.1861 0.3722 0.55830.744
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Figure 3.29 Effect of EDTA on inhibitory activity of non-dairy Microgard against
Saccharomyces cerevisiae var ellipsoideus 1B150 0.1 0.5 1 1.5
sodium citrate
2
152
INOriginal Cell Count
elSodium Citrate Control
EM Sodium Citrate+MG
Figure 3.30 Effect of sodium citrate on inhibitory activity of non-dairy Microgard
against Candida albicans ATCC 1880400.03722 0.1861 0.3722 0.5583 0.7444
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Figure 3.31Effect of EDTA on inhibitory activity of non-dairy Microgard against
Candida albicans ATCC 18804109
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Figure 3.32 Effect of citrate on inhibitory activity of dairy Microgard against
Pseudomonas putida in cottage cheese1010
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Figure 3.33 Effect of citrate on inhibitory activity of dairy Microgard against
Saccharomyces cerevisiae in cottage cheese109
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Figure 3.34 Effect of citrate on inhibitory activity of dairy Microgard against
Pseudomonas putida in half and half cream10
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Figure 3.35 Effect of citrate on inhibitory activity of Microgard against
Saccharomyces cerevisae in half and half cream109
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Figure 3.36 Effect of citrate on inhibitory activity of dairy Microgard against
Candida albicans in half and half creamTable 3.1
159
Effect of diluting MicrogardTm (MG) in various diluents on inhibitory
activity against Pseudomonas putida ATCC 12633. MG was
serologically diluted with 0.1 M citrate buffer (pH 5.30), 0.1 M
HEPES buffer (pH 5.30), or distilled water. Disk-activity assay (pH
5.30) was performed for each diluted fraction against Ps. putida.
Plates were incubated at 30 °C for 18 hours.
dilu.
samp
1:2 1:4 1:8 1:161:321:641:1281:2561:51210242048409681926384
Citrb
e
3.302.802.502.001.551.552.101.601.752.002.002.403.301.80
c
H2O3.403.102.652.501.751.45NIa NI NI NI NI NI NI NI
d
HEP3.753.252.401.751.451.45 NI NI NI NI NI NI NI NI
a. "NI" denotes non-inhibitory
b. "Citr" denotes citrate-buffer used as diluent
c. "H20" denotes water used as diluent
d. "HEP" denotes HEPES-buffer used as diluent
e. All inhibitory zones are measured in cm-diameter
f.Blank disk diameter is 1.3 cm160
Table 3.2The effect of MicrogardTM -citrate treatment on Gram-negative and
Gram-postive bacteria and yeasts
Log reduction of bacteriala and yeastb
population after treatment at 30 °C for
30 minutes
Organism
MicrogardTM
treatment
MicrogardTM- citrate
treatment
Pseudomonas putida ATCC 126330 2.48e 6.84
Pseudomonas aeruginosa ATCC 4.041 3.59
101454
Escherichia coli 0157:H7d 1.061 1.55
Salmonella typhimurium ATCC 1.62e 1.56
796310
Listeria monocytogenes ATCC 8940-EV 2.29
Saccaromyces cerevisiae var
ellipsoideus 1B1 5d
0.86f 1.38
Candidaalbicans ATCC 18804d 0.046f 0.34
a Untreated bacterial cell populations -6.9 X107 /ml for Ps. putida, -5.0X107/m1
for Ps. aeruginosa, -2.5 X109/m1 for E. coli, -1.7 X108/m1 for S. typhimurium,
and -1.01 X108/mlfor L. monocytogenes,
b Untreated yeast cell populations -1.66 X106 /ml for S. cerevisiae, and -7.0
X108/mlfor C. albicans.
C American Type Culture Collection, Rockville, Md.
d Oregon State University Culture Collection, Corvallis, Or.
e Diluted MicrogardTM (1:2) from Wesman Foods, Inc., Beaverton, Or.
f Undiluted MicrogardTM from Wesman Foods, Inc., Beaverton, Or.161
Table 3.3The effect of MicrogardTM -EDTA treatment on Gram-negative and
Gram-postive bacteria and yeasts
Log reduction of bacteriala and yeastb
population after treatment at 30 °C for
30 minutes
Organism
MicrogardTM
treatment
MicrogardTM -EDTA
treatment
Pseudomonas putida ATCC 12633c2.33e 4.16
Pseudomonas aeruginosa ATCC 4.66f 5.42
10145c
Escherichia coli 0157:H7d 2.41f 1.88
Salmonella typhimurium ATCC 2.25e 1.84
79631c
Listeria monocytogenes ATCC 894c1.33f 1.93
Saccaromyces cerevisiae var
ellipsoideus 1 B15d
1.11f 1.25
Candidaalbicans ATCC 18804c 0.18f 0.17
a Untreated bacterial cell populations -5.3 X107 /ml for Ps. putida,. - 2.1X107/ml
for Ps. aeruginosa, -3.85 X109/m1 for E. coli, -1.4 X108/m1 for S. typhimurium,
and -9.3 X107/mlfor L. monocytogenes,
b Untreated yeast cell populations -4.0 X106 /ml for S. cerevisiae, and -9.2
X106/mlfor C. albicans.
C American Type Culture Collection, Rockville, Md.
d Oregon State University Culture Collection, Corvallis, Or.
e Diluted MicrogardTM (1:2) from Wesman Foods, Inc., Beaverton, Or.
f Undiluted MicrogardTM from Wesman Foods, Inc., Beaverton, Or.162
REFERENCES
Asperger, H., B. Url, and E. Brandt. 1989. Interactions between Listeria and the
ripening flora of cheese. Neth. Milk Dairy J. 43:287-298.
Barefoot, S. F., and C. G. Nettles. 1993. Antibiosis revisited: bacteriocins
produced by dairy starter cultures. J. Dairy Sci. 76:2366-2379.
Benkerroum, N., and W. E.Sandine. 1988. Inhibitory action of nisin against
Listeria monocytogenes. J. Dairy Sci. 71:3237-3245.
Bhunia, A. K., M. C. Johnson, B. Ray, and N. Kalchayanand. 1991. Mode of
action of pediocin AcH from Pediococcus acidilactici H on sensitive
bacterial strains. J. Appl. Bacteriol. 70:25-33.
Blackburn, P., J. Polak, S-A Gusik, and S. D. Rubino. 1989. Nisin for use as
enhanced, broad range bactericides. International Patent Application
(PCT), WO 89/12399.
Blackman, P., J. Polak, S. Gusik, and S. D. Rubino. 1989. Nisin compositions for
use as enhanced, broad range bacteriocins.International patent
application number PCT/US89/02625; international publication number
W089/12399. Applied Microbiology. Inc., New York.
Bodyfelt, F. W., and W. D. Davidson. 1975. Temperature control: I. A procedure
for profiling temperatures of dairy products in stores. J. Milk Food Technol.
38:734-737.
Bruno, M. E. C., and T. Montville. 1993. Common mechanistic action of
bacteriocins from lactic acid bacteria. Appl. Environ. Microbiol. 59:3003-
3010.
Carminati, D., G. Giraffa, and M. G. Bossi. 1989. Bacteriocin-like inhibitors of
Streptococcus lactis against Listeria monocytogenes. J. food Prot. 52:614-
617.
Christensen, D. P., and R. W. Hutkins. 1992. Collapse of the proton motive force
in Listeriamonocytogenes caused by a bacteriocin produced by
Pediococcus acidilactici. Appl. Environ. Microbiol. 58:3312-3315.
Coughlin, R. T., C. R. Caldwell, A. Haug, and E. J. McGroarty. 1981. A cationic
electron spin resonance probe used to analyze cation interactions with
lipopolysaccharide. Biochem. Biophys. Res. Comm. 100:1137-1142.
Daeschel, M. A. 1990. Applications of bacteriocins in food systems. p.91-104. In
D.D. Bills and S. Kung (ed.), Biotechnology and food safety. Butterworth-
Heinemann, Stoneham, M.A.163
Dorrer,E., and M. Teuber. 1977. Induction of polymyxin resistance in
Pseudomonas fluorescensby phosphate limitation. Arch. Microbiol.
114:87-89.
EI-Gazzar, F. E., and E. H. Marth. 1991. Listeria monocytogenes and listeriosis
related to milk, milk products and dairy ingredients: a review. II Listeria
monocytogenes and dairy technology. Milchwissenschaft. 46:82-86.
Garcera, M. J. G., M. G. L. Elferink, A. J. M. Driessen, and W. N. Konings. 1993.
In vitro pore-forming activity of the lantibiotic nisin. Role of protonmotive
force and lipid composition. Eur. J. Biochem. 212:417-422.
Glauert, A. M., and M. J. Thorn ley. 1969. The topography of the bacterial cell
wall. Ann. Rev. Microbiol. 23:159-198.
Graham, G. S., R. W. Treick, and D. P. Brunner. 1979. Effect of Ca2+ and Mg2+
upon the reassociation by Escherichia coli of material released by
ethylenediaminetetraacetate. Curr. Microbiol. 2:339-343.
Gray, G. W., and S. G. Wilkinson. 1965.the effect of ethylenediaminetetra-
acetic acid on the cell walls of some Gram-negative bacteria. J. Gen.
Microbiol. 39:385-399.
Gross, E., and J. L. Morrell. 1967. The presence of dehydroalanine in the
antibiotic nisin and its relationship to activity. J. Am. Chem. Soc. 89:2791-
2792.
Gross, E., and J. L. Morrell. 1971. The structure of nisin. J. Am. Chem. Soc.
93:4634-4635.
Hancock, R. E. W. 1984. Alterations in outer membrane permeability. Annu. Rev.
Microbiol. 38:237-264.
Harris, L. J., M. A. Daeschel, M. E. Stiles, and T. R. Klaenhammer. 1989.
Antimicrobialactivityoflacticacidbacteria againstListeria
monocytogenes. J. Food Prot. 52:384-387.
Kim, W. J. 1993. Bacteriocins of lactic acid bacteria: Their potentials as food
preservative. Food Rev. Int. 9(2):299-313.
Kordel, M., F. Schtliller, and H.-G. Sahl. 1989. Interaction of the pore forming-
peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes.
J. Fed. Eur. Biochem. Soc. Lett. 244:99-102.
Kordel, M., and H.-G. Sahl.1986. Susceptibility of bacterial, eukaryotic and
artificial membranes to the disruptive action of the cationic peptides Pep 5
and nisin. FEMS Microb. Lett. 34:139-144.164
Leive, L. 1965. Release of lipopolysaccharide by EDTA treatment of E. coll.
Biochem. Biophy. Res. Comm. 21:290-296.
Leive, L., V. K. Shovlin, and S. E. Mergenhagen. 1968. Physical, chemical, and
immunological properties of lipopolysaccharide released from Escherichia
coli by ethylenediaminetetraacetate. J. Biol. Chem. 243:6384-6391.
Liu, W., and J. N. Hansen. 1990. Some chemical and physical properties of
nisin, a small-protein antibiotic produced by Lactococcus lactis. Appl.
Environ. Microbiol. 56:2551-2558.
Lugtenberg, B., and L. van Alphen. 1983. Molecular architecture and
functioning of the outer membrane of Escherichia coli and other Gram-
negative bacteria. Biochem. Biophys. Acta. 737:51-115.
Maisnier-Patin, S., N. Deschamps, S. R. Tatini, J. Richard. 1992. Inhibition of
Listeria monocytogenes in Camembert cheese made with a nisin-
producing starter.Lait. 72:249-263.
Mohamed G. E. E., A. Seaman, M. Woodbine. (ed.) 1984. Food antibiotic nisin:
comparative effects on Erysipelothrix and Listeria. In "Antimicrobials and
Antibiosis in Agriculture." Butterworths, London.
Morris, S. L., R. C. Walsh, and J. N. Hansen. 1984. Identification and
characterization of some bacterial membrane sulfhydryl groups which are
targets of bacteriostatic and antibiotic action. J. Biol. Chem. 259:13590-
13594.
Murray, R. G. E., P. Steed, and H. E. Elson. 1965. The location of the
mucopeptide in sections of the cell wall of Escherichia coli and other
Gram-negative bacteria. Can. J. Microbiol. 11:547-560.
Nikaido, H., and M. Vaara. 1985. Molecular basis of bacterial outer membrane
permeability. Microbiol. Rev. 49:1-32.
Nikaido, H., and M. Vaara. 1987. Outer membrane, p.7-22. In F.C. Neidhardt
(ed.), Escherichia coli and Salmonella typhimurium:cellular and
molecular biology, vol. 1.. American Society for Microbiology, Washington,
D.C.
Nikaido, H., and T. Nakae. 1979. The outer membrane of gram-negative
bacteria. Adv. Microb. Physiol. 20:163-250.
Okereke, A., and T. J. Montville. 1992. Nisin dissipates the proton motive force
of the obligate anaerobe Clostridium sporogenes PA 3679. Appl. Environ.
Microbiol. 58:2463-2467.
Ray, B. 1993. Sublethal injury, bacteriocins, and food microbiology. ASM News.
59:285-291.165
Roberts, N. A., G. W. Gray, and S. G. Wilkinson. 1970. The bactericidal action of
ethylenediaminetetra-acetic acid on Pseudomonas aeruginosa. Microbios.
2:189-208.
Rogers, S. W., H. E. Jr. Gilleland, and R. G. Eagon. 1969. Characterization of a
protein-lipopolysaccharide complex released fromcellwallsof
Pseudomonasaeruginosa by ethylenediaminetetraacetic acid. Can. J.
Microbiol. 15:743-748.
Roller, S. 1991. The biotechnological development of new food preservatives.
Biotechnol. Genet. Eng. Rev. 9:183-206.
Ruhr, E., and H.-G. Sahl. 1985. Mode of action of the peptide antibiotic nisin and
influence on the membrane potential of whole cells and on cytoplasmic
and artificial membrane vesicles. Antimicrob. Agents Chemother. 27:841-
845.
Schinder, M., and M. J. Osborn. 1979. Interaction of divalent cations and
polymyxin B with lipopolysaccharide. Biochemistry. 18:4425-4430.
Schmitges, C. J., and U. Henning. 1976. The major proteins of the Escherichia
coli outer cell-envelope membrane. Eur. J. Biochem. 63:47-52.
Schwab, A. H., H. V. Leininger, and E. M. Powers. 1984. Compendium of
methods for the microbiological examination of foods. p. 855-856, Ch. 58
In " Media, reagents, and stains." American Public Health Association,
Washington, D.C.
Skovgaard, N. 1990. the impact of the prevalence of Listeria monocytogenes in
the environment on meat and milk hygiene. Microbiol. Alim. Nutr. 8:15-20.
Smit, J., and H. Nikaido. 1978. Outer membrane of Gram-negative bacteria.
XVIII. Electron microscopic studies on porin insertion sites and growth of
cell surface of Salmonella typhimurium. J. Bacteriol. 135:687-702.
Stanier, R. Y., J. L. Ingraham, M. L. Wheelis, and P. R. Painter (ed.). 1986. The
Microbial World. p.158-159. In Ch. 6. "The relations between structure and
function in procaryotic cells." Prentice-Hall. Englewood Cliffs, N.J.
Stevens, Kelly A., Brian W. Sheldon, N. Arlene Klapes, and Todd R.
Klaenhammer. 1991. Nisin treatment of inactivation of Salmonella species
and other gram-negative bacteria. Appl. Environ. Microbiol. 57:3613-3615.
Stevens, Kelly A.,N. Arlene Klapes, Brian W. Sheldon, and Todd
Klaenhammer. 1992a. Antimicrobial action of nisin against Salmonella
typhimuriumlipopolysaccharide mutants.Appl. Environ. Microbiol.
58:1786-1788.166
Stevens, K. A., B. W. Sheldon, N. A. Klapes, and T. R. Klaenhammer. 1992b.
Effect of treatment conditions on nisin inactivation of gram-negative
bacteria. J. Food Prot. 55:763-766.
Sykes, R., and A. Morris. 1975. Resistance of Pseudomonas aeruginosa to
antimicrobial drugs. Prog. Med. Chem. 12:333-393.
Walker, C. A., and N. N. Durham. 1975. Effect of carbon source during growth
on sensitivity of Pseudomonas fluorescens to actinomycin D. Can. J.
Microbiol. 21:69-74.
White, D. A., and W. J. Lennarz, and C. A., Schnaitman. 1972. Distribution of
lipids in the wall and cytoplasmic membrane subfractions of the cell
envelope of Escherichia coll. J. Bacteriol. 109:686-690.
Windholz, M., S. Budavari, R. F. Blumetti, and E. S. Otterbein (ed.) 1983. The
Merck Index. p. 2292 and p. 3486. Merck & Co., Inc. Rahway, N.J.
Yamada, H., and S. Mizushima. 1980. Interaction between major outer
membrane protein (0-8) and lipopolysaccharide in Escherichia coli K12.
Eur. J. Biochem. 103:209-218.167
CONCLUSIONS
Research reported in this thesis showed that the inhibitory activity of
MicrogardTM (MG) could not solely be due to acetic, propionic and lactic acidsor
diacetyl.The removal of organic acids corresponded to an increase in the
specific activity of MG. The antimicrobial substance(s) in MG is thermal stable
and does not resemble the active precursors of lactoferrin when hydrolyzed
under acidic or basic conditions. Also, the active compound is proteineous in
nature resembling the characteristics of bacteriocins or microcins. The active
peptide was eluted from reverse-phase HPLC by a low concentration of organic
solvent (6-10% acetonitrile) suggesting hydrophillicity of the compound.
Analysis by mass spectroscopy showed that the peptide has a molecular
weight of 881.7 daltons. The result agrees with previous estimations from ultra-
filtration (between 500 and 1000 daltons), gel-filtration (860 daltons) and
amino-acid analysis (926 daltons).The peptide was found to contain eight
residues consisting of 4 methionine, 2 of valine, 1 of glutamine/glutamate, and
possibly 1 of glycine.
Chelating agents such as sodium citrate or EDTA have been shown to
potentiate the antimicrobial activity of MG against a wider range of bacteria and
yeasts.The incubation time for chelating agents may be crucial in that
organisms possessing different membrane structures have varying amounts of
stabilizing cations on their surfaces.Incorporation of food-grade chelating
agents and MG holds promise for use in the extension of shelf-life of various
foods.
Future work on MG remains exciting. The peptide will be sequenced and
synthesized in -vitro.After which, probes can be made from the synthesized
peptide and its nucleotide bases determined and cloned into lactic acid bacteria168
to induce the production of this bacteriocin.Numerous strains of various
species can be produced in this manner for use in food preservation.The
active MicrogardTM peptide likely also will find use in human medicine.169
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